phosphorus has been researched along with Hyperphosphatemia in 245 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (0.41) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 50 (20.41) | 29.6817 |
| 2010's | 160 (65.31) | 24.3611 |
| 2020's | 34 (13.88) | 2.80 |
| Authors | Studies |
|---|---|
| Chon, Y; Drayer, D; Goodman, WG; Lai, J; Martin, KJ; Moore, C; Nemeth, EF; Ward, DT; Xu, J | 1 |
| Coyne, DW; Kalantar-Zadeh, K; Ramos, R; Sprague, SM; Vervloet, M | 1 |
| de Santa Rosa, RG; Farias, MLF; Garcia, MI; Gomes, CP; Gottlieb, I; Madeira, M; Polonine, S | 1 |
| Hashimoto, T; Ito, K; Matsumoto, Y; Nishino, N; Okuda, Y; Susai, H; Yamada, R; Yokoyama, K | 1 |
| da Silva, REC; Kunii, IS; Lazaretti-Castro, M; Pallone, SG | 1 |
| Dwyer, JP; Kelepouris, E | 1 |
| Ahmadipour, H; Alinaghi Langari, A; Alinaghi Langari, T; Azmandian, J; Masoumi, H; Mousavi, M; Shamspour, N; Talaei Khales Soflaei, B | 1 |
| Andrews, ES; Kendrick, J; Perez, L; Ramirez-Renteria, L; Reddin, R; Teitelbaum, I; Wilson, G; You, Z | 1 |
| Ahn, JP; Hwang, J; Kang, WK; Kim, HJ; Moon, SJ | 1 |
| Fukui, K; Gao, J; Hashimoto, A; Kanome, Y; Kohno, M; Nakatsu, M; Ogawa, Y | 1 |
| Anger, MS; Ficociello, LH; Mullon, C; Rhee, CM; Woznick, R; Zhou, M | 1 |
| Gupta, A; Kapoor, V; Sachan, T; Saxena, A | 1 |
| Cao, X; Deng, W; Liu, B; Wang, H; Wang, Z; Yan, D; Yang, J; Yang, W; Zuo, Q | 1 |
| Chen, Y; Cui, X; Jiang, S; Liu, L; Tang, X | 1 |
| Campos Del Portillo, R; Contreras Angulo, M; Ferreira de Vasconcelos Carvalho, R; Nocete Aragón, I; Palacios García, N; Sanz-Aranguez Ávila, B | 1 |
| Dărăban, AM; Elian, V; Karampelas, O; Licu, M; Mititelu, M; Moroșan, E; Popovici, V; Rusu, AI | 1 |
| Amadeu de Oliveira, F; Andras, NL; Chu, EY; Eltilib, LA; Foster, BL; Kinoshita, Y; Millán, JL; Mohamed, FF; Narisawa, S; Tani, T; Yalamanchili, RR | 1 |
| Biruete, A; Hill Gallant, KM; Kistler, BM; Lloyd, L; Meade, A; Moe, SM; St-Jules, DE | 1 |
| Ai, X; Dong, H; Feng, J; Huang, B; Huang, X; Li, J; Li, L; Li, X; Luo, H; Wang, J; Xiao, H; Xue, G; You, S; Zhang, Y | 1 |
| Bakhtiari, N; Hosseini, M; Nasiri, M; Vasli, P | 1 |
| Akizawa, T; Fukagawa, M; Koiwa, F; Nakanishi, K; Ohara, M; Sato, Y | 1 |
| Barreto, FC; Bucharles, SGE; Riella, MC | 1 |
| Bellorin-Font, E; Martin, KJ; Vasquez-Rios, G | 1 |
| Chin, HJ; Han, SS; Joo, KW; Kim, S; Kim, YS; Moon, H; Na, KY | 1 |
| Hong, KY; Kim, HS; Kim, K; Kim, WS; Kwon, E; Lee, JH; Lee, YT; Min, JJ; Park, J | 1 |
| Barash, Y; Grossman, E; Klang, E; Leibowitz, A; Shlomai, G; Soffer, S; Zimlichman, E | 1 |
| Jiang, M; Wan, T; Wang, Y; Xu, C; Zheng, H | 1 |
| Covic, AC; Floege, J; Ketteler, M; Perrin, A; Rastogi, A; Sprague, SM; Walpen, S | 1 |
| Akizawa, T; Asada, S; Fujii, N; Fukagawa, M; Fukuhara, S; Fukuma, S; Kato, C; Miyakoshi, C; Nomura, T; Onishi, Y; Wada, M | 1 |
| Abitbol, CL; Ahn, SY; Balgradean, M; Enoiu, M; Fathallah-Shaykh, S; Fila, M; Greenbaum, LA; Jankauskiene, A; Jeck, N; Klaus, G; Nelson, R; Paredes, A; Perrin, A; Stoica, C; Swinford, RD; Wickman, L | 1 |
| Fan, X; He, G; Li, M; Li, Q; Mao, Q; Zhang, S; Zhang, W; Zhang, X | 1 |
| Chertow, GM; Pergola, PE; Rosenbaum, DP; Yang, Y | 1 |
| Akihisa, T; Tsuchiya, K | 1 |
| Akizawa, T; Fukagawa, M; Ikejiri, K; Kanda, H; Shigematsu, T; Une, Y | 1 |
| Mager, DR; Picard, K; Richard, C | 1 |
| Breda, J; Correia, A; Dinis, A; Garagarza, C; Godinho, J; Jesus, J; Oliveira, T; Valente, A | 1 |
| Li, P; Lian, R; Yin, J; Zheng, J | 1 |
| Chao, JE; Grobe, N; Kotanko, P; Tao, X; Tapia, LM; Thijssen, S; Thwin, O; Wang, LC; Zhang, H | 1 |
| Hao, CM; Shang, B; Shang, D; Xie, Q; You, L; Zhang, M; Zhu, T | 1 |
| Ariceta, G; Dell, KM; Dufek, MB; Eldred, A; Greenbaum, LA; Hoppe, B; Lee, HJ; Lerner, G; Linde, P; Warady, BA; Webb, NJA | 1 |
| Araujo, RM; Barretti, P; Caramori, JCT; Vogt, BP; Watanabe, MT | 1 |
| Akizawa, T; Fukagawa, M; Koiwa, F; Yokoyama, K | 1 |
| Chazot, G; Juillard, L; Lemoine, S | 1 |
| Bostom, A; Carpenter, MA; Foster, MC; Gohh, R; House, AA; Ix, JH; Jacques, P; Kew, CE; Kim, SJ; Kusek, JW; Levey, AS; Merhi, B; Pesavento, TE; Pfeffer, M; Rao, M; Shireman, T; Smith, SR; Weiner, DE | 1 |
| Anderson, L; Coyne, DW; Ficociello, LH; Kossmann, RJ; Maddux, FW; Mullon, C; Ofsthun, NJ; Parameswaran, V; Sprague, SM; Vemula, S | 1 |
| Evers, SMAA; Hiligsmann, M; Karavetian, M; Rizk, R | 1 |
| Bai, Q; Guo, H; Li, Y; Liu, H; Yang, X; Zhang, X | 1 |
| St Peter, WL; Wazny, LD; Weinhandl, ED | 1 |
| Li, M; Xie, D; Ye, N | 1 |
| Hayashi, H; Ichie, T; Sugiura, Y; Sugiyama, T; Suzuki, D | 1 |
| Anderson, L; Coyne, DW; Ficociello, LH; Kalantar-Zadeh, K; Kossmann, RJ; Kwoh, C; Mullon, C; Ofsthun, NJ; Parameswaran, V | 1 |
| Li, H; Lu, X; Wang, F; Wang, S; Xiong, R; Zhang, J | 1 |
| Fukagawa, M; Hida, M; Kakuta, T; Komaba, H; Suga, T; Wada, T | 1 |
| Covic, AC; Floege, J; Ketteler, M; Rakov, V; Rastogi, A; Spinowitz, B; Sprague, SM; Walpen, S | 1 |
| Parmar, MS | 1 |
| Jolly, S; Kaur, T; Nakhoul, GN; Nally, JV; Rincon-Choles, H; Sekar, A | 1 |
| Ma, T; Zhang, P; Zhang, Y | 1 |
| Chien, KL; Chiu, YL; Hsu, SP; Liu, LC; Peng, YS; Tsai, SM; Tsai, WC; Wu, HY | 1 |
| Hamdi, T; Moe, OW; Pak, CYC; Pasch, A; Quiñones, H; Sakhaee, K | 1 |
| Gao, D; Gong, JH; Liu, JJ; Lu, L; Qin, YF; Xu, Q; Yuan, H | 1 |
| Davis, S; Ficociello, LH; Kalantar-Zadeh, K; Kendrick, J; Kossmann, RJ; Mullon, C; Ofsthun, NJ; Parameswaran, V | 1 |
| Brink, DM; Daugirdas, JT; Kapoian, T; Khalil, S; O'Mara, NB | 1 |
| Han, M; Li, J; Li, Y; Liao, R; Maharjan, A; Su, B; Sun, S; Wang, L; Xiong, Y | 1 |
| Ix, JH; Lau, WL | 1 |
| Kalakeche, R; Rennick, A; Seel, L; Shepler, B | 1 |
| Hasegawa, Y; Kamo, Y; Kikuchi, N; Matsuda, E; Sekino, H; Sekino, M; Takeuchi, K | 1 |
| Inaba, M; Ito, A; Nitta, K; Otsubo, S; Satoh, S; Tanaka, M; Tominaga, Y; Yajima, A | 1 |
| Kabaya, T; Mitsuhashi, T; Miyajima, S; Nitta, K; Ogawa, T; Ohba, T; Otsuka, K; Shizuku, J; Takahashi, M; Takahashi, N; Yamashita, T | 1 |
| Brunelli, SM; Jing, J; Kalantar-Zadeh, K; Kovesdy, CP; Lau, WL; Lertdumrongluk, P; Molnar, MZ; Moradi, H; Nissenson, AR; Park, J; Rhee, CM | 1 |
| Caldas, Y; Giral, H; Levi, M; Sorribas, V | 1 |
| Wojcicki, JM | 1 |
| Chen, J; Chen, N; Dillon, M; Ding, X; Fu, J; Fu, P; Hou, F; Huang, C; Hunter, J; Jiang, G; La, Y; Li, X; Liu, B; Mei, C; Neylan, J; Ni, Z; Plone, M; Wang, L; Wu, X; Xing, C; Yu, X; Zuo, L | 1 |
| Tonelli, M | 1 |
| Adema, AY; de Borst, MH; Ter Wee, PM; Vervloet, MG | 1 |
| Dellanna, F; Dimkovic, N; Locatelli, F; Pontoriero, G; Spasovski, G; Wanner, C | 1 |
| Akizawa, T; Kameoka, C; Kaneko, Y; Kawasaki, S | 1 |
| Kuro-o, M | 1 |
| Collinson, A; McMullan, M; Sadler, H; Tse, WY | 1 |
| Chong, EM; Covic, AC; Floege, J; Gaillard, S; Ketteler, M; Lisk, LJ; Rastogi, A; Sprague, SM | 1 |
| Geach, T | 1 |
| Galani, VJ; Prajapati, VA; Shah, PR | 1 |
| Akiba, T; Chertow, GM; Fukagawa, M; Hirakata, H; Kumagai, Y; Nakayama, M; Sawada, K; Yokoyama, K | 1 |
| Chiang, SS; Lee, CT; Peng, YS; Shu, KH; Wu, IW; Wu, MJ; Wu, MS | 1 |
| Gomes-Filho, IS; Guerra, RN; Libério, SA; Lopes, FF; Pereira, AL; Rodrigues, VP; Thomaz, EB | 1 |
| Ando, R; Chida, Y; Inagaki, Y; Inoue, A; Ishida, Y; Iwamoto, S; Kikuchi, K; Kimura, H; Ohnishi, T; Ohtsuka, M; Tachibana, K; Takayama, M; Yama, S; Yamada, K | 1 |
| Hara, K; Kishi, Y; Kurosawa, N; Obara, Y; Takada, D; Yamashiro, H | 1 |
| Haruhara, K; Kamejima, S; Kanzaki, G; Mafune, H; Manabe, M; Mashiko, H; Okamoto, H; Yokoo, T | 1 |
| Kumagai, J; Mukai, I; Takahashi, N; Tsuchiya, S; Yoshizawa, T | 1 |
| Akizawa, T; Asano, Y; Fukagawa, M; Hara, H; Kasahara, H; Komemushi, S; Maeda, Y; Matsui, N; Miyauchi, Y; Niwayama, J; Okada, Y; Sasaki, N; Suda, A; Suzuki, T; Tsuruta, Y | 1 |
| Furukawa, K; Ikawa, T; Kato, K; Takahashi, J; Ueno, M; Yokoi, S; Yokouchi, S | 1 |
| Gen, S; Ikeda, N; Nobe, K; Nodaira, Y; Saito, K; Sasaki, T | 1 |
| Ban, A; Funao, K; Furumitsu, Y; Hata, K; Inoue, K; Makino, R; Okamura, M; Shima, H; Sugita, S; Yoshimoto, M | 1 |
| Akizawa, T; Kameoka, C; Kaneko, Y; Kanoh, H; Origasa, H | 1 |
| Ito, K; Kumata, C; Matsuzaka, K; Nakajima, Y; Ogata, H; Shishido, K; Takeshima, A; Wakasa, M | 1 |
| Alonso, A; Astor, BC; Coresh, J; Folsom, AR; Loehr, LR; Lutsey, PL; Michos, ED | 1 |
| Athreya, BP; Blumenthal, SS; Chang, IJ; Chuang, P; Dwyer, JP; Galphin, CM; Greene, T; Kant, KS; Koury, MJ; Lewis, JB; Linfert, DR; Manley, J; Nossuli, AK; Olivero, JJ; Schulman, G; Sika, M; Smith, MT; Whittier, FC; Zeig, S | 1 |
| Maizel, J; Massy, ZA | 1 |
| Tuchman, S | 1 |
| Carter, SM; Hagemann, TM; Johnson, PN; Miller, JL; Miller, MM | 1 |
| Hutchison, AJ | 1 |
| Fang, W; Jiang, N; Lin, A; Ni, Z; Qian, J; Yang, X; Yuan, J; Zhang, L | 1 |
| Hou, Y; Liu, J; Shi, Y; Zhao, Y | 1 |
| Dwyer, JP; Niecestro, R; Rodby, R; Sinsakul, M; Umanath, K | 1 |
| Arif, A; Doyle, AM; Khan, TA; Seamonds, B | 1 |
| López-Guerra, EA; Rodríguez-Castellanos, FE; Rodríguez-García, VH | 1 |
| Block, G; Isakova, T | 1 |
| Fukagawa, M; Hida, M; Kakuta, T; Komaba, H; Suga, T; Suzuki, H | 1 |
| Braunhofer, P; Claxton, AJ; Deuson, J; Lubeck, D; Newsome, B; Ramakrishnan, K; Wang, S | 1 |
| Anker, SD; Doehner, W; Hudzik, B; Jankowska, EA; Kawecka, E; Kokocińska, D; Myrda, K; Niedziela, J; Nowak, J; Partyka, R; Poloński, L; Ponikowski, P; Rozentryt, P; Rywik, T; Szyguła, B; von Haehling, S | 1 |
| Chong, EM; Covic, AC; Floege, J; Gaillard, S; Ketteler, M; Lisk, LJ; Mann, JF; Rastogi, A; Spinowitz, B; Sprague, SM | 1 |
| Baiko, S; Bakkaloğlu, S; Battelino, N; Bonthuis, M; Busutti, M; Gaydarova, M; Gianoglio, B; Gomes, C; Groothoff, JW; Heaf, JG; Jager, KJ; Kuzmanovska, D; Molchanova, MS; Pankratenko, TE; Papachristou, F; Parvex, P; Podracka, L; Reusz, G; Sanahuja, MJ; Schaefer, F; Shroff, R; van Stralen, KJ; Verrina, E | 1 |
| Cannata-Andía, JB; Martin, KJ | 1 |
| Abrams, SA; Chetta, KE; Hair, AB; Hawthorne, KM | 1 |
| Browne, T; Cavanaugh, K; Ikizler, TA; Lewis, JB; Merighi, JR; Umanath, K; Umeukeje, EM; Victoroff, JN; Wallston, KA | 1 |
| Carlson, S; Hamilton-Reeves, JM; Oladitan, L; Taylor, JM | 1 |
| Amiri, FS | 1 |
| Dembek, KA; Kamr, AM; Reed, SM; Rosol, TJ; Slovis, NM; Toribio, RE; Zaghawa, AA | 1 |
| Campbell, K; Day, S; Ferguson, M; McCutcheon, J; Rossi, M | 1 |
| Dimkovic, N; Hertel, J; Locatelli, F; Spasovski, G; Wanner, C | 1 |
| Bellamy, S; Feldman, HI; Glanz, K; Levsky, S; Mgbako, O; Mussell, A; Parikh, CR; Potluri, V; Reese, PP; Shults, J; Volpp, K; Yekta, Z | 1 |
| Chen, J; Li, M; Zhang, Q | 1 |
| Chen, Y; Li, Z; Liang, X; Shi, W; Xu, L; Zhang, M; Zhang, Y; Zhong, L | 1 |
| Chin, HJ; Choi, Y; Heo, NJ; Joo, KW; Kang, S; Kim, YS; Lee, H; Oh, KH; Yang, SH; Yoo, KD | 1 |
| El Borolossy, R; El Hakim, I; El Wakeel, LM; Sabri, N | 1 |
| Kakuta, H; Taniguchi, K | 1 |
| Abcar, AC; Cheung, MY; Henry, SL; Jacobsen, SJ; Joson, CG; Kim, S; Morisky, DE; Parab, P; Sim, JJ | 1 |
| Guan, YF; Wang, J; Zhang, XY | 1 |
| Dimkovic, N; Locatelli, F; Spasovski, G; Wanner, C | 1 |
| Dai, H; Degnan, A; Henderson, S; Oladitan, L; Taylor, JM; Warady, BA | 1 |
| Huang, CC; Lin, HH; Liou, HH; Wu, MS | 1 |
| Alsmaan, H; Browne, T; Cavanaugh, KL; Lewis, JB; Merighi, JR; Umanath, K; Umeukeje, EM; Wallston, KA; Wild, M | 1 |
| Brazier, M; Brisset, S; Choukroun, G; El Esper, N; Fournier, A; Kamel, S; Lemaire-Hurtel, AS; Lenglet, A; Liabeuf, S; Mansour, J; Mary, A; Massy, ZA; Mentaverri, R | 1 |
| Koiwa, F; Terao, A | 1 |
| Akizawa, T; Fukagawa, M; Koiwa, F; Terao, A; Yokoyama, K | 1 |
| Wang, F; Wang, JW; Zhang, LX; Zhao, MH; Zhou, C | 1 |
| de Fornasari, ML; Dos Santos Sens, YA | 1 |
| Koiwa, F; Taketani, Y; Yokoyama, K | 1 |
| Burgu, B; Kendirli, T; Kurt-Şükür, ED; Ödek, Ç; Özçakar, ZB; Telli, O; Yaman, A | 1 |
| Caetano, C; Garagarza, C; Oliveira, T; Ponce, P; Silva, AP; Valente, A | 1 |
| Han, YY; Li, SH; Liu, J; Sun, YP; Yang, WJ | 1 |
| Fukagawa, M; Komaba, H; Tanaka, M | 1 |
| Hamada, C; Hasegawa, H; Higuchi, C; Hiramatsu, M; Hosoya, T; Itami, N; Kasai, K; Kawaguchi, Y; Kawanishi, H; Kubota, M; Masakane, I; Minakuchi, J; Mitarai, T; Nakao, T; Suzuki, H; Tomo, T; Yamamoto, H | 1 |
| Anger, M; Fishbane, S; Martin, KJ; Mehrotra, R; Sprague, SM; Zeig, S | 1 |
| Barnett, ME; Hutchison, AJ; Krause, R; Kwan, JT; Siami, GA | 1 |
| Caputo, F; Chasan-Taber, S; Duggal, A; Evenepoel, P; Fan, S; Foggensteiner, L; Heaf, JG; Kelly, A; Ortiz, A; Selgas, R | 1 |
| Rodríguez Portillo, M | 1 |
| Torregrosa Prats, V | 1 |
| Valdivieso, JM | 1 |
| Fernandez Giraldez, E; Sánchez González, MC; Valdivielso Revilla, JM | 1 |
| Ghosh, AK; Joshi, SR | 1 |
| Abboud, H; Dauphin, M; Finn, W; Qiu, P; Sprague, SM; Zhang, P | 1 |
| Bellinghieri, G; Calò, LA; Mallamace, A; Monardo, P; Muraca, U; Santoro, D; Savica, V | 1 |
| Kalantar-Zadeh, K; Kovesdy, CP | 2 |
| Cannata-Andía, JB; Naves-Díaz, M | 1 |
| Guidi, GC; Lippi, G; Montagnana, M; Salvagno, GL; Targher, G | 1 |
| Fukagawa, M; Komaba, H | 1 |
| Tanaka, M | 1 |
| Leon, JB; Love, TE; Machekano, R; Marbury, M; Porter, D; Sayre, SS; Sehgal, AR; Sullivan, C | 1 |
| Cannata-Andía, JB; Carrillo-López, N; Román-García, P | 1 |
| Hutchison, AJ; Mohammed, I | 1 |
| Chiarelli, G; Levin, A; Lim, L; Sigrist, MK | 1 |
| Delaney, M | 1 |
| Eknoyan, G | 1 |
| Filson, J; Nguyen, TV | 1 |
| Bos, WJ; Bouman, K; Braun, J; Brink, H; Carter, D; Frazão, JM; Graf, H; Macário, F; Maduell, F; Messa, P; Pontoriero, G; Reichel, H; Saha, H; Torregrosa, V; von Albertini, B; Wilkie, M; Yaqoob, M; Zani, VJ | 1 |
| Amo, K; Harada, N; Higashi, Y; Isshiki, M; Nakaya, Y; Nashiki, K; Sato, M; Shuto, E; Takeda, E; Taketani, Y; Tanaka, R; Yamamoto, H | 1 |
| Adzize, T; Chiu, YW; de Leon, EM; Mehrotra, R; Misra, M; Teitelbaum, I | 1 |
| Agrawal, N; McChesney, LP; Nair, R; Suneja, M; Thomas, CP; Tuteja, S | 1 |
| Lopes, AA; Lopes, GB | 1 |
| Chertow, GM; Ix, JH | 1 |
| Ganguli, A | 1 |
| Andress, DL; Joyce, AT; Kalantar-Zadeh, K; Marx, SE; Schumock, GT; Sterz, R | 1 |
| Craig, JC; Elder, GJ; Navaneethan, SD; Palmer, SC; Strippoli, GF | 1 |
| Dimkovic, N; Kostic, S; Locatelli, F; Manning, A; Nakajima, S; Pljesa, S; Pontoriero, G; Sano, H; Spasovski, G | 1 |
| Wolf, M | 1 |
| Chew, D; Kidder, AC | 1 |
| Breves, G; Mrochen, N; Schröder, B; Wilkens, MR | 1 |
| Evenepoel, P; Meijers, B | 1 |
| Peacock, M | 1 |
| Finch, JL; Lane, N; Nakamura, H; Shahnazari, M; Slatopolsky, E; Tokumoto, M; Yao, W | 1 |
| Collins, TC; Criqui, MH; Cummings, SR; Ix, JH; Kestenbaum, BR; Lewis, CE; Meng, J; Wassel, CL | 1 |
| Bostom, AG; Hanlon, WA; Kuznetsova, O; Maccubbin, D; Tipping, D | 1 |
| Abercrombie, EL; Baxter, DH; Greenbaum, LA; Hopkins, B | 1 |
| Anderson, JE; Kalantar-Zadeh, K; Kovesdy, CP | 1 |
| Amer, A; Block, GA; Brillhart, SL; Persky, MS; Slade, AJ | 1 |
| Alonso Alvarez, MA; Díez Ojeda, B; Medrano Martínez, S | 1 |
| Martin, KJ; Qazi, RA | 1 |
| Benedyk-Lorens, E; Covic, AC; de Francisco, AL; Ketteler, M; Leidig, M; Mircescu, GM; Passlick-Deetjen, J; Ponce, P; Scholz, C | 1 |
| Enfield, G; Gutiérrez, OM; Isakova, T; Wolf, M | 1 |
| Bax, JJ; Chonchol, M; Flu, WJ; Poldermans, D; Valentijn, TM; van Kuijk, JP; Verhagen, HJ | 1 |
| Hofman-Bang, J; Lewin, E; Martuseviciene, G; Olgaard, K; Santini, MA | 1 |
| Bunch, TH; Jensen, GM; Laybourne, S; Wolf, S | 1 |
| Kalantar-Zadeh, K; Kovesdy, CP; Kuchmak, O; Lu, JL | 1 |
| Ahlenstiel, T; Ariceta, G; Bak, M; Bakkaloglu, SA; Borzych, D; Chua, A; Ha, IS; Hari, P; Klaus, G; Lipka, M; Lopez, L; Ozaltin, F; Printza, N; Rees, L; Schaefer, F; Spizzirri, AP; Valles, PG; Vogel, A; Warady, BA; Yap, HK; Zambrano, P | 1 |
| Chen, YM; Chiang, WC; Chu, TS; Huang, CY; Huang, JW; Hung, KY; Kan, WC; Kao, TW; Lin, SL; Lin, YF; Tsai, TJ; Wu, KD; Wu, MS; Yen, CJ | 1 |
| Bellinghieri, G; Calò, LA; Davis, PA; Monardo, P; Muraca, U; Santoro, D; Santoro, G; Savica, V | 1 |
| Devnath, S; Hossain, S; Keka, SI; Mahmud, I; Masum, N; Rahman, Z | 1 |
| Abbaspour, MR; Belladi Musavi, SS; Ghorbani, A; Hayati, F; Lashkarara, GR; Shahbazian, H; Zafar Mohtashami, A | 1 |
| Arisaka, H; Nakaoka, A; Shigematsu, T; Tokumoto, A | 1 |
| Gardulf, A; Nicolay, U; Pålsson, M | 1 |
| Fujii, H; Fujimori, A; Fukagawa, M; Goto, S; Hasegawa, H; Kamae, I; Kim, JI; Komaba, H; Moriwaki, K; Nishi, S; Nishioka, M; Shibuya, K; Shin, J; Taniguchi, M; Yoshiya, K | 1 |
| Challa, AS; Dounousi, EC; Karasavvidou, DP; Katopodis, KP; Vlachou, IA | 1 |
| Ghaddar, S; Saoud, IP | 1 |
| Chrul, S; Dryja, P; Kacprzyk, F; Króliczak, V; Zwiech, R; Łacina, D | 1 |
| Freistätter, O; Knoll, F; Kronenberg, F; Lamina, C; Lhotta, K; Lins, F; Neyer, U; Sturm, G; Zitt, E | 1 |
| Matalon, A; Michelis, MF; Vemuri, N | 1 |
| Brunner-Ziegler, S; Fröschl, B; Hiebinger, C; Zsifkovits, J | 1 |
| Barreto, FC; de Oliveira, RA; Jorgetti, V; Oliveira, RB | 1 |
| Moe, SM; Moorthi, RN | 1 |
| Crawford, A; Harris, H | 1 |
| Caravaca, F; Cerezo, I; Ferreira, F; García de Vinuesa, E; Hernández-Gallego, R; Macías, R; Martínez del Viejo, C; Martínez Gallardo, R; Villa, J | 1 |
| Dennis, K; Pennick, M; Poole, L; Smyth, M | 1 |
| Wang, X; Zeng, M; Zhao, X | 1 |
| Ayus, JC; Chertow, GM; Daugirdas, JT; Greene, T; James, SH; Kendrick, CA; Kliger, AS; Larive, B; Miller, BW; Pierratos, A; Salusky, IB; Schulman, G | 1 |
| Bobeck, EA; Cook, ME; Helvig, C; Meyer, KM; Petkovich, M | 1 |
| Chi, WC; Lin, CH; Liu, YC; Wu, YW; Yap, YS | 1 |
| Alvarez, R; Bielsa, S; Campos, B; Castilla, J; Caverni, A; García, M; Gimeno, JA; Gutiérrez, A; Lou, LM; Martin, F; Moreno, R; Pérez, J; Sanz, A | 1 |
| Barmada, A; Slavin, RE; Wen, J | 1 |
| Aarabi, M; Emami Zeydi, A; Espahbodi, F; Gholipour Baradari, A | 1 |
| Fukushima, S; Hagino, S; Kanasaki, T; Matsumoto, T | 1 |
| Chiyotanda, S; Fujimoto, S; Fukudome, K; Kitamura, K; Sato, Y; Toida, T; Yamada, K | 1 |
| Ahmadi, F; Khatami, MR; Lessan-Pezeshki, M; Shamekhi, F | 1 |
| Chen, J; Chen, N; Chen, W; Chen, X; Ding, F; Fan, M; Gu, Y; He, L; Hou, F; Jia, Q; Kong, X; Liu, W; Mei, C; Ni, Z; Peng, L; Shi, W; Shu, G; Tang, X; Wang, H; Wang, L; Wang, M; Wu, H; Xing, C; Xiong, Z; Xu, D; Yu, X; Yuan, W; Zhang, J; Zhang, L; Zuo, L | 1 |
| Kido, S; Nomura, K; Sasaki, S; Segawa, H; Shiozaki, Y; Tatsumi, S | 1 |
| Cooper, K; Goodman, W; Kubo, Y; Quarles, D; Tomlin, H | 1 |
| Kalantar-Zadeh, K; Kovesdy, CP; Li, J; Molnar, MZ; Salusky, I; Sim, JJ; Streja, E; Zaritsky, JJ | 1 |
| Belén Martín, M; Bennouna, M; Blanco, A; Dolores Arenas, M; Lerma, JL; Luisa Muñiz, M; Mauricio, O; Pérez-García, R; Prados, MD | 1 |
| Anger, M; Blumenthal, SS; Chang, IJ; Dwyer, JP; Kaplan, M; Koury, MJ; Lewis, JB; Schulman, G; Sika, M; Smith, M; Zeig, S | 1 |
| Chao, MC; Chen, JB; Chen, TH; Hung, KY; Liao, SC | 1 |
| Ayus, JC; Nolan, CA; Qunibi, WY | 1 |
| LINNEWEH, F; STAVE, U | 1 |
| Achinger, SG; Ayus, JC | 1 |
| Bellinghieri, G; Caldarera, R; Calò, LA; Cavaleri, A; Granata, A; Monardo, P; Muraca, U; Santoro, D; Savica, R; Savica, V | 1 |
| Dong, J; Wang, H; Wang, M | 1 |
| Mizukami, K; Okada, M; Terai, K | 1 |
| Boeschoten, EW; Bos, WJ; Bossuyt, PM; Dekker, FW; Geskus, RB; Korevaar, JC; Krediet, RT; Noordzij, M | 1 |
| Block, GA; Bushinsky, DA; Chertow, GM; Chi, EM; Sugihara, J; Turner, SA; Zeig, S | 1 |
| Akçiçek, F; Akpolat, T; Arinsoy, T; Ataman, R; Ateş, K; Bozfakioğlu, S; Camsari, T; Dimitriades, AC; Dombros, NA; Ersoy, FF; Evaggelos, DM; Gültekin, M; Karayaylali, I; Katopodis, KP; Oreopoulos, DG; Ozener, C; Passadakis, PS; Stathakis, CP; Süleymanlar, G; Tam, P; Tsakiris, DJ; Utaş, C; Vlachojannis, GJ; Wu, G; Yavuz, A; Yavuz, M; Yilmaz, ME | 1 |
| Cheng, SC; Coyne, DW; Delmez, JA; Huang, Y; Young, DO | 1 |
| Date, T; Funakoshi, S; Hashiguchi, J; Itoh, K; Kono, T; Kubo, H; Masaki, K; Nakano, H; Shigematsu, T; Tanaka, M; Uchino, J | 1 |
| Bellinghieri, G; Calã, LA; Davis, PA; Savica, V | 1 |
| Bates, JA | 1 |
| Chasan-Taber, S; Duggal, A; Fan, S; Heaton, J; Kalra, PA; Ketteler, M; Oestergaard, O; Pritchard, N; Rix, M | 1 |
| Moe, SM | 1 |
51 review(s) available for phosphorus and Hyperphosphatemia
| Article | Year |
|---|---|
Sucroferric oxyhydroxide for hyperphosphatemia: a review of real-world evidence.
Topics: Drug Combinations; Ferric Compounds; Humans; Hyperphosphatemia; Iron; Phosphates; Phosphorus; Prospective Studies; Randomized Controlled Trials as Topic; Renal Dialysis; Retrospective Studies; Sucrose | 2022 |
New Directions in Phosphorus Management in Dialysis.
Topics: Humans; Hyperphosphatemia; Kidney Failure, Chronic; Phosphates; Phosphorus; Quality of Life; Renal Dialysis | 2023 |
'Phos'tering a Clear Message: The Evolution of Dietary Phosphorus Management in Chronic Kidney Disease.
Topics: Diet; Humans; Hyperphosphatemia; Phosphorus; Phosphorus, Dietary; Renal Insufficiency, Chronic | 2023 |
Efficacy and safety of tenapanor in hemodialysis patients with hyperphosphatemia: A systematic review and meta-analysis of randomized placebo-controlled trials.
Topics: Diarrhea; Double-Blind Method; Humans; Hyperphosphatemia; Phosphorus; Randomized Controlled Trials as Topic; Renal Dialysis | 2023 |
Controversies in the Management of Secondary Hyperparathyroidism in Chronic Kidney Disease.
Topics: Calcimimetic Agents; Chelating Agents; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Hypocalcemia; Parathyroid Hormone; Phosphorus; Renal Insufficiency, Chronic; Vitamin D | 2019 |
Meta-Analysis Treatment Hyperphosphatemia Chronic Renal Failure Based on Nano Lanthanum Hydroxide.
Topics: Calcium; Humans; Hydroxides; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Phosphates; Phosphorus; Renal Dialysis; Treatment Outcome | 2020 |
The Importance of Phosphate Control in Chronic Kidney Disease.
Topics: Aging; Animals; Bone and Bones; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperphosphatemia; Klotho Proteins; Membrane Proteins; Parathyroid Hormone; Phosphates; Phosphorus; Renal Insufficiency, Chronic; Risk Factors; Vascular Calcification | 2021 |
The Impact of Protein Type on Phosphorus Intake, Serum Phosphate Concentrations, and Nutrition Status in Adults with Chronic Kidney Disease: A Critical Review.
Topics: Humans; Hyperphosphatemia; Nutritional Status; Phosphates; Phosphorus; Phosphorus, Dietary; Renal Insufficiency, Chronic | 2021 |
Comparative Efficacy and Safety of Phosphate Binders in Hyperphosphatemia Patients With Chronic Kidney Disease.
Topics: Bile Acids and Salts; Calcium; Calcium Compounds; Chelating Agents; Humans; Hyperphosphatemia; Iron; Iron Compounds; Niacin; Parathyroid Hormone; Phosphates; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic | 2018 |
A systematic review on the efficacy and safety of PA21 versus sevelamer in dialysis patients.
Topics: Calcium; Chelating Agents; Ferric Compounds; Hypercalcemia; Hyperphosphatemia; Kidney Failure, Chronic; Phosphorus; Randomized Controlled Trials as Topic; Renal Dialysis; Sevelamer | 2018 |
Effect of Lanthanum Carbonate on All-Cause Mortality in Patients Receiving Maintenance Hemodialysis: a Meta-Analysis of Randomized Controlled Trials.
Topics: Calcium; Cardiovascular Diseases; Humans; Hyperphosphatemia; Lanthanum; Mortality; Parathyroid Hormone; Phosphorus; Randomized Controlled Trials as Topic; Renal Dialysis | 2018 |
Phosphorus binders: The new and the old, and how to choose.
Topics: Chelating Agents; Humans; Hyperphosphatemia; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic | 2018 |
Efficacy and safety of nicotinamide on phosphorus metabolism in hemodialysis patients: A systematic review and meta-analysis.
Topics: Calcium; Humans; Hyperphosphatemia; Lipids; Niacinamide; Parathyroid Hormone; Phosphorus; Randomized Controlled Trials as Topic; Renal Dialysis | 2018 |
The role of phosphate-containing medications and low dietary phosphorus-protein ratio in reducing intestinal phosphorus load in patients with chronic kidney disease.
Topics: Humans; Hyperphosphatemia; Phosphorus; Phosphorus, Dietary; Renal Insufficiency, Chronic | 2019 |
Clinical detection, risk factors, and cardiovascular consequences of medial arterial calcification: a pattern of vascular injury associated with aberrant mineral metabolism.
Topics: Atherosclerosis; Cardiovascular Diseases; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Monckeberg Medial Calcific Sclerosis; Phosphorus; Renal Insufficiency, Chronic; Risk Factors; Vascular Calcification | 2013 |
Nicotinic acid and nicotinamide: a review of their use for hyperphosphatemia in dialysis patients.
Topics: Animals; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Niacin; Niacinamide; Peritoneal Dialysis; Phosphorus; Renal Dialysis | 2013 |
Nuclear receptor LXR: a new partner for sodium-dependent phosphate cotransporters.
Topics: Animals; Biological Transport, Active; Bone and Bones; Cholesterol; Cytokines; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glucuronidase; Homeostasis; Humans; Hyperphosphatemia; Intestinal Absorption; Intestine, Small; Kidney Tubules; Klotho Proteins; Liver X Receptors; Mice; Models, Biological; Nuclear Proteins; Orphan Nuclear Receptors; Phosphorus; Rats; Signal Transduction; Sodium; Sodium-Phosphate Cotransporter Proteins | 2013 |
Dietary and pharmacological modification of fibroblast growth factor-23 in chronic kidney disease.
Topics: Calcium; Calcium, Dietary; Cardiovascular Diseases; Chelating Agents; Cinacalcet; Diet; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperphosphatemia; Lanthanum; Naphthalenes; Phosphorus; Phosphorus, Dietary; Polyamines; Renal Insufficiency, Chronic; Sevelamer | 2014 |
[Pleiotropic effects of sevelamer: a model of intestinal tract chelating agent].
Topics: Animals; Bone Remodeling; Cardiovascular Diseases; Chelating Agents; Chelation Therapy; Disease Models, Animal; Endothelium, Vascular; Glycation End Products, Advanced; Humans; Hyperphosphatemia; Inflammation; Intestinal Absorption; Lipid Metabolism; Mice; Phosphorus; Phosphorus, Dietary; Randomized Controlled Trials as Topic; Renal Dialysis; Renal Insufficiency, Chronic; Sevelamer; Toxins, Biological; Uremia; Uric Acid | 2014 |
Disorders of mineral metabolism in the newborn.
Topics: Calcium; Disease Progression; Fibroblast Growth Factor-23; Homeostasis; Humans; Hypercalcemia; Hyperphosphatemia; Hypocalcemia; Hypophosphatemia; Infant, Newborn; Kidney; Minerals; Parathyroid Hormone; Phosphorus; Rickets | 2014 |
Educational intervention for metabolic bone disease in patients with chronic kidney disease: a systematic review and meta-analysis.
Topics: Biomarkers; Bone Diseases, Metabolic; Calcium; Databases, Factual; Health Knowledge, Attitudes, Practice; Humans; Hyperphosphatemia; Patient Education as Topic; Phosphorus; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Treatment Outcome | 2014 |
Ferric citrate spans mineral metabolism and anemia domains in ESRD: a review of efficacy and safety data.
Topics: Anemia; Chelating Agents; Ferric Compounds; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Phosphates; Phosphorus | 2014 |
The challenge of controlling phosphorus in chronic kidney disease.
Topics: Fibroblast Growth Factor-23; Humans; Hyperphosphatemia; Phosphorus; Phosphorus, Dietary; Renal Insufficiency, Chronic | 2016 |
Contemporary management of phosphorus retention in chronic kidney disease: a review.
Topics: Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperphosphatemia; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic | 2015 |
Effect of colestilan on serum phosphorus in dialysis patients: A meta-analysis of the literature.
Topics: Bile Acids and Salts; Biomarkers; Chelating Agents; Chi-Square Distribution; Humans; Hyperphosphatemia; Odds Ratio; Phosphorus; Randomized Controlled Trials as Topic; Renal Dialysis; Time Factors; Treatment Outcome | 2016 |
Management of phosphorus load in CKD patients.
Topics: Animals; Bone Diseases, Metabolic; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperphosphatemia; Minerals; Phosphorus; Phosphorus, Dietary; Renal Insufficiency, Chronic | 2017 |
Treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD).
Topics: Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Japan; Naphthalenes; Parathyroid Hormone; Phosphorus; Practice Guidelines as Topic; Vitamin D | 2008 |
[Introduction to lanthanum carbonate: pharmacology, safety and tolerability].
Topics: Animals; Bone and Bones; Chelating Agents; Chelation Therapy; Clinical Trials as Topic; Drug Evaluation, Preclinical; Humans; Hyperphosphatemia; Intestinal Absorption; Kidney Failure, Chronic; Lanthanum; Liver; Nervous System; Phosphorus; Rats; Tissue Distribution | 2008 |
[Lanthanum carbonate in clinical practice].
Topics: Administration, Oral; Chelating Agents; Chelation Therapy; Clinical Trials as Topic; Gastrointestinal Diseases; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Liver; Phosphorus; Tablets | 2008 |
[Experimental advances in mineral metabolism].
Topics: Animals; Calcinosis; Calcium; Cardiovascular Diseases; Chelating Agents; Chelation Therapy; Chronic Disease; Drug Evaluation, Preclinical; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Intestinal Absorption; Kidney; Kidney Diseases; Lanthanum; Phosphorus; Sodium-Phosphate Cotransporter Proteins | 2008 |
[Control of phosphorus and treatment with vitamin D in chronic kidney disease prior to the start of dialysis].
Topics: Calcifediol; Calcinosis; Calcitriol; Cardiovascular Diseases; Chronic Disease; Chronic Kidney Disease-Mineral and Bone Disorder; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperphosphatemia; Kidney Diseases; Lanthanum; Phosphorus; Polyamines; Prevalence; Renal Dialysis; Sevelamer; Vitamin D; Vitamin D Deficiency | 2008 |
Disorders of calcium, phosphorus and magnesium metabolism.
Topics: Calcium; Hospitalization; Humans; Hypercalcemia; Hyperphosphatemia; Hypophosphatemia; Hypotension; Magnesium; Metabolic Diseases; Phosphorus; Risk Factors | 2008 |
[Disturbance of phosphorus metabolism in chronic kidney disease].
Topics: Biomarkers; Chronic Disease; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glomerular Filtration Rate; Humans; Hyperphosphatemia; Hypophosphatemia; Kidney Diseases; Kidney Transplantation; Parathyroid Hormone; Phosphorus | 2009 |
[Management of phosphate in chronic kidney disease--Phosphorus control by hemodialysis with long treatment time].
Topics: Chronic Disease; Humans; Hyperphosphatemia; Kidney Diseases; Phosphorus; Prognosis; Renal Dialysis; Time Factors | 2009 |
Pathogenesis of bone and mineral related disorders in chronic kidney disease: key role of hyperphosphatemia.
Topics: Aluminum Hydroxide; Calcinosis; Calcitriol; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Diet, Protein-Restricted; Disease Progression; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Phosphorus; Phosphorus, Dietary; Renal Dialysis; Risk Factors; Vascular Diseases | 2009 |
Oral phosphate binders for the management of serum phosphate levels in dialysis patients.
Topics: Acetates; Administration, Oral; Aluminum Hydroxide; Calcium Carbonate; Calcium Compounds; Cardiovascular Diseases; Chelating Agents; Drug Monitoring; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Magnesium; Nephrology; Patient Education as Topic; Phosphorus; Polyamines; Practice Guidelines as Topic; Renal Dialysis; Sevelamer; Treatment Outcome | 2009 |
Early initiation of phosphate lowering dietary therapy in non-dialysis chronic kidney disease: a critical review.
Topics: Cardiovascular Diseases; Chelating Agents; Disease Progression; Evidence-Based Practice; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Food Additives; Guideline Adherence; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Menu Planning; Nephrology; Nutritive Value; Phosphorus; Phosphorus, Dietary; Practice Guidelines as Topic; Risk Factors; Treatment Outcome | 2009 |
Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials.
Topics: Acetates; Biomarkers; Bone Density Conservation Agents; Calcium; Calcium Carbonate; Calcium Compounds; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hypercalcemia; Hyperphosphatemia; Lanthanum; Parathyroid Hormone; Phosphates; Phosphorus; Polyamines; Randomized Controlled Trials as Topic; Renal Insufficiency, Chronic; Research Design; Sevelamer | 2009 |
Fibroblast growth factor 23 and the future of phosphorus management.
Topics: Animals; Biomarkers; Calcitriol; Chelating Agents; Chronic Disease; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperphosphatemia; Kidney Diseases; Patient Selection; Phosphorus; Predictive Value of Tests; Renal Dialysis; Reproducibility of Results; Risk Assessment; Up-Regulation | 2009 |
Treatment options for hyperphosphatemia in feline CKD: what's out there?
Topics: Animals; Calcium Carbonate; Cat Diseases; Cats; Chelating Agents; Diet; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Parathyroid Hormone; Phosphates; Phosphorus; Prognosis | 2009 |
Calcium metabolism in health and disease.
Topics: Animals; Bone and Bones; Bone Remodeling; Calcium; Calcium, Dietary; Chronic Disease; Dietary Supplements; Homeostasis; Humans; Hypercalcemia; Hyperphosphatemia; Hypocalcemia; Hypophosphatemia; Intestinal Mucosa; Kidney; Kidney Diseases; Metabolic Diseases; Nutrition Policy; Phosphates; Phosphorus; Vitamin D | 2010 |
Vitamin D in kidney disease: pathophysiology and the utility of treatment.
Topics: Animals; Calcium; Cardiovascular System; Chronic Disease; Dietary Supplements; Fractures, Bone; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Diseases; Mice; Phosphorus; Vitamin D; Vitamin D Deficiency | 2010 |
Salivary glands: a new player in phosphorus metabolism.
Topics: Chewing Gum; Chitosan; Glomerular Filtration Rate; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Phosphorus; Renal Dialysis; Saliva; Salivary Glands | 2011 |
Pharmacotherapy of chronic kidney disease and mineral bone disorder.
Topics: Animals; Bone Density Conservation Agents; Bone Diseases, Metabolic; Calcimimetic Agents; Humans; Hyperphosphatemia; Kidney Diseases; Phosphorus; Vitamin D | 2011 |
Balancing act: calcium & phosphorus.
Topics: Calcium; Humans; Hypercalcemia; Hyperphosphatemia; Hypocalcemia; Hypophosphatemia; Nursing Assessment; Phosphorus; Water-Electrolyte Balance | 2012 |
[Information about phosphorus additives and nutritional counseling].
Topics: Food Additives; Humans; Hyperphosphatemia; Phosphorus; Phosphorus, Dietary; Renal Dialysis; Renal Insufficiency, Chronic | 2012 |
Cardiovascular calcification in patients with end-stage renal disease: a century-old phenomenon.
Topics: Calcinosis; Calcium; Chelating Agents; Coronary Artery Disease; Dialysis; History, 20th Century; History, 21st Century; Humans; Hypercalcemia; Hyperphosphatemia; Kidney Failure, Chronic; Muscle, Smooth, Vascular; Parathyroid Hormone; Phosphorus; Risk Factors; Vitamin D; Vitamins | 2002 |
Left ventricular hypertrophy: is hyperphosphatemia among dialysis patients a risk factor?
Topics: Humans; Hyperphosphatemia; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Phosphorus; Renal Dialysis; Risk Factors | 2006 |
Bone and mineral disorders in pre-dialysis CKD.
Topics: Bone Density Conservation Agents; Chronic Disease; Comorbidity; Disease Progression; Ergocalciferols; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glomerular Filtration Rate; Humans; Hyperparathyroidism; Hyperphosphatemia; Kidney Diseases; Phosphorus; Vitamin D; Vitamin D Deficiency | 2008 |
Phosphorus: a quick reference.
Topics: Animals; Hyperphosphatemia; Parathyroid Hormone; Phosphorus; Reference Values | 2008 |
Disorders involving calcium, phosphorus, and magnesium.
Topics: Calcium; Humans; Hypercalcemia; Hyperphosphatemia; Hypocalcemia; Hypophosphatemia; Magnesium; Metabolic Diseases; Phosphorus | 2008 |
66 trial(s) available for phosphorus and Hyperphosphatemia
| Article | Year |
|---|---|
Family-centered empowerment approach to optimize phosphate management among hemodialysis patients: an experimental study.
Topics: Humans; Hyperphosphatemia; Phosphates; Phosphorus; Phosphorus, Dietary; Renal Dialysis | 2023 |
Long-term safety and decrease of pill burden by tenapanor therapy: a phase 3 open-label study in hemodialysis patients with hyperphosphatemia.
Topics: Humans; Hyperphosphatemia; Phosphates; Phosphorus; Renal Dialysis; Sodium-Hydrogen Exchanger 3 | 2023 |
Characteristics of Patients Who Achieve Serum Phosphorus Control on Sucroferric Oxyhydroxide or Sevelamer Carbonate: A post hoc Analysis of a Phase 3 Study.
Topics: Adult; Age Factors; Aged; Calcimimetic Agents; Chelating Agents; Drug Combinations; Female; Ferric Compounds; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperphosphatemia; Logistic Models; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Sevelamer; Sucrose; Vitamin D | 2020 |
Safety and efficacy of sucroferric oxyhydroxide in pediatric patients with chronic kidney disease.
Topics: Adolescent; Child; Drug Combinations; Ferric Compounds; Humans; Hyperphosphatemia; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Sucrose | 2021 |
A Randomized Trial of Tenapanor and Phosphate Binders as a Dual-Mechanism Treatment for Hyperphosphatemia in Patients on Maintenance Dialysis (AMPLIFY).
Topics: Adult; Aged; Chelating Agents; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Female; Fibroblast Growth Factor-23; Humans; Hyperphosphatemia; Isoquinolines; Male; Middle Aged; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Sevelamer; Sodium-Hydrogen Exchanger 3; Sulfonamides | 2021 |
Therapeutic Effects of Add-On Tenapanor for Hemodialysis Patients with Refractory Hyperphosphatemia.
Topics: Aged; Chelating Agents; Diarrhea; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hyperphosphatemia; Isoquinolines; Male; Medication Adherence; Middle Aged; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Sodium-Hydrogen Exchangers; Sulfonamides | 2021 |
Dietary Advice in Hemodialysis Patients: Impact of a Telehealth Approach During the COVID-19 Pandemic.
Topics: Calcium; Counseling; COVID-19; Female; Humans; Hyperkalemia; Hyperphosphatemia; Hypophosphatemia; Kidney Failure, Chronic; Longitudinal Studies; Male; Nutritional Status; Pandemics; Phosphorus; Potassium; Prospective Studies; Renal Dialysis; Telemedicine | 2022 |
Implementation and effectiveness of an intensive education program on phosphate control among hemodialysis patients: a non-randomized, single-arm, single-center trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chelating Agents; Diet; Female; Health Knowledge, Attitudes, Practice; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Medication Adherence; Middle Aged; Patient Education as Topic; Phosphorus; Program Evaluation; Renal Dialysis; Socioeconomic Factors; Young Adult | 2021 |
Hyperphosphatemia and hs-CRP Initiate the Coronary Artery Calcification in Peritoneal Dialysis Patients.
Topics: Adult; Aged; Blood Pressure; C-Reactive Protein; Coronary Artery Disease; Female; Fibrinogen; Follow-Up Studies; Humans; Hyperphosphatemia; Lipoproteins, HDL; Male; Middle Aged; Peritoneal Dialysis; Phosphorus; Risk Factors; Vascular Calcification | 2017 |
Efficacy and safety of paricalcitol in children with stages 3 to 5 chronic kidney disease.
Topics: Adolescent; Bone Density Conservation Agents; Calcium; Child; Double-Blind Method; Ergocalciferols; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Male; Parathyroid Hormone; Phosphorus; Renal Dialysis; Treatment Outcome | 2017 |
Long-Term Assessment of the Safety and Efficacy of PA21 (Sucroferric Oxyhydroxide) in Japanese Hemodialysis Patients With Hyperphosphatemia: An Open-Label, Multicenter, Phase III Study.
Topics: Aged; Asian People; Drug Combinations; Female; Ferric Compounds; Humans; Hyperphosphatemia; Japan; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Sucrose; Treatment Outcome | 2017 |
Serum Phosphorus and Risk of Cardiovascular Disease, All-Cause Mortality, or Graft Failure in Kidney Transplant Recipients: An Ancillary Study of the FAVORIT Trial Cohort.
Topics: Adult; Cardiovascular Diseases; Female; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Kidney Transplantation; Male; Middle Aged; Outcome and Process Assessment, Health Care; Phosphorus; Postoperative Complications; Risk Factors; Survival Analysis; Transplant Recipients | 2017 |
Cost-effectiveness of dedicated dietitians for hyperphosphatemia management among hemodialysis patients in Lebanon: results from the Nutrition Education for Management of Osteodystrophy trial.
Topics: Chronic Kidney Disease-Mineral and Bone Disorder; Cost of Illness; Cost-Benefit Analysis; Humans; Hyperphosphatemia; Lebanon; Models, Econometric; Nutritionists; Patient Education as Topic; Phosphorus; Quality of Life; Quality-Adjusted Life Years; Renal Dialysis; Time Factors | 2017 |
Effects of sucroferric oxyhydroxide and sevelamer carbonate on chronic kidney disease-mineral bone disorder parameters in dialysis patients.
Topics: Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Drug Combinations; Female; Ferric Compounds; Fibroblast Growth Factor-23; Follow-Up Studies; Humans; Hyperphosphatemia; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Sevelamer; Sucrose; Time Factors; Treatment Outcome | 2019 |
Control of metabolic predisposition to cardiovascular complications of chronic kidney disease by effervescent calcium magnesium citrate: a feasibility study.
Topics: Acid-Base Equilibrium; Acidosis; Aged; Bicarbonates; Biomarkers; Calcium Citrate; Cardiovascular Diseases; Citric Acid; Cross-Over Studies; Drug Combinations; Feasibility Studies; Female; Humans; Hydrogen-Ion Concentration; Hyperphosphatemia; Magnesium; Magnesium Compounds; Magnesium Deficiency; Male; Middle Aged; Organometallic Compounds; Parathyroid Hormone; Phosphates; Phosphorus; Renal Insufficiency, Chronic; Texas; Time Factors; Treatment Outcome | 2019 |
[Effect of Rhubarb Combined Medicinal Activated Carbon on Levels of Serum Phosphorus, Calci- um-Phosphorus Product, and Parathyroid Hormone in Hemodialysis Patients with Hyperphosphatemia].
Topics: Calcium; Carbon; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Parathyroid Hormone; Phosphorus; Plant Extracts; Renal Dialysis; Rheum | 2016 |
Three-year follow-up of lanthanum carbonate therapy in hemodialysis patients.
Topics: Adult; Aged; Calcium; Calcium Carbonate; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hypercalcemia; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Phosphates; Phosphorus; Polyamines; Renal Dialysis; Sevelamer; Vitamin D | 2013 |
Additional reduction in serum phosphorus levels by pulverized lanthanum carbonate chewable in hemodialysis patients.
Topics: Administration, Oral; Aged; Female; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Mastication; Middle Aged; Phosphorus; Renal Dialysis | 2013 |
Sevelamer carbonate lowers serum phosphorus effectively in haemodialysis patients: a randomized, double-blind, placebo-controlled, dose-titration study.
Topics: Adult; Aged; Chelating Agents; Cholesterol, LDL; Double-Blind Method; Female; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Phosphates; Phosphorus; Polyamines; Renal Dialysis; Sevelamer; Young Adult | 2014 |
The effects of colestilan versus placebo and sevelamer in patients with CKD 5D and hyperphosphataemia: a 1-year prospective randomized study.
Topics: Adult; Aged; Aged, 80 and over; Bile Acids and Salts; Biomarkers; Calcium; Cholesterol; Female; Humans; Hyperphosphatemia; Male; Middle Aged; Phosphorus; Polyamines; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic; Sevelamer; Young Adult | 2014 |
A phase III study of the efficacy and safety of a novel iron-based phosphate binder in dialysis patients.
Topics: Adult; Aged; Chelating Agents; Constipation; Diarrhea; Female; Ferric Compounds; Humans; Hyperphosphatemia; Induction Chemotherapy; Maintenance Chemotherapy; Male; Medication Adherence; Middle Aged; Nausea; Patient Dropouts; Peritoneal Dialysis; Phosphorus; Polyamines; Renal Insufficiency, Chronic; Sevelamer | 2014 |
Long-term safety and efficacy of a novel iron-containing phosphate binder, JTT-751, in patients receiving hemodialysis.
Topics: Aged; Calcium; Dose-Response Relationship, Drug; Endpoint Determination; Female; Ferric Compounds; Ferritins; Gastrointestinal Diseases; Hematinics; Humans; Hyperphosphatemia; Iron; Male; Middle Aged; Parathyroid Hormone; Phosphates; Phosphorus; Renal Dialysis | 2014 |
Effect of oral ferric citrate on serum phosphorus in hemodialysis patients: multicenter, randomized, double-blind, placebo-controlled study.
Topics: Administration, Oral; Adult; Aged; Chelating Agents; Double-Blind Method; Female; Ferric Compounds; Ferritins; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Renal Dialysis; Transferrin | 2015 |
Multicenter study on the long-term (3-year) efficacy of lanthanum carbonate in dialysis patients.
Topics: Aged; Calcium; Female; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Time Factors; Treatment Outcome | 2014 |
Clinical effects of long-term (36-month) lanthanum carbonate administration in hemodialysis patients in Japan.
Topics: Aged; Calcium; Calcium Carbonate; Chelating Agents; Dose-Response Relationship, Drug; Female; Humans; Hyperphosphatemia; Japan; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Polyamines; Renal Dialysis; Sevelamer; Time Factors; Treatment Outcome | 2014 |
Effect of chitosan chewing gum on reducing serum phosphorus in hemodialysis patients: a multi-center, randomized, double-blind, placebo-controlled trial.
Topics: Administration, Oral; Adult; Aged; Chewing Gum; Chitosan; Delayed-Action Preparations; Double-Blind Method; Female; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Placebo Effect; Renal Dialysis; Treatment Outcome | 2014 |
Dose-finding study of bixalomer in patients with chronic kidney disease on hemodialysis with hyperphosphatemia: a double-blind, randomized, placebo-controlled and sevelamer hydrochloride-controlled open-label, parallel group study.
Topics: Chelating Agents; Dose-Response Relationship, Drug; Double-Blind Method; Hyperphosphatemia; Japan; Phosphorus; Polyamines; Renal Dialysis; Renal Insufficiency, Chronic; Sevelamer; Treatment Outcome | 2014 |
Ferric citrate controls phosphorus and delivers iron in patients on dialysis.
Topics: Anemia, Iron-Deficiency; Dose-Response Relationship, Drug; Female; Ferric Compounds; Humans; Hyperphosphatemia; Iron; Israel; Kidney Failure, Chronic; Male; Middle Aged; Outcome Assessment, Health Care; Phosphorus; Renal Dialysis; Treatment Outcome; United States | 2015 |
Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patients.
Topics: Drug Combinations; Female; Ferric Compounds; Humans; Hyperphosphatemia; Iron; Male; Middle Aged; Phosphorus; Prognosis; Renal Dialysis; Sucrose; Time Factors | 2015 |
Randomized, Double-Blind, Placebo-Controlled, Withdrawal Study of Colestilan after Dose Titration in Chronic Kidney Disease Dialysis Patients with Hyperphosphatemia.
Topics: Adult; Aged; Aged, 80 and over; Bile Acids and Salts; Calcium; Dose-Response Relationship, Drug; Double-Blind Method; Endpoint Determination; Female; Glycated Hemoglobin; Humans; Hyperphosphatemia; Lipids; Male; Middle Aged; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Treatment Outcome; Young Adult | 2015 |
A Pilot Randomized Trial of Financial Incentives or Coaching to Lower Serum Phosphorus in Dialysis Patients.
Topics: Adult; Aged; Aged, 80 and over; Feasibility Studies; Female; Health Promotion; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Motivation; Patient Compliance; Phosphorus; Pilot Projects; Renal Dialysis; Reward | 2015 |
Efficacy and safety of nicotinamide in the management of hyperphosphatemia in pediatric patients on regular hemodialysis.
Topics: Adolescent; Chelating Agents; Child; Female; Follow-Up Studies; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Niacinamide; Phosphorus; Renal Dialysis; Vitamin B Complex | 2016 |
Long-Term Evaluation of Colestilan in Chronic Kidney Disease Stage 5 Dialysis Patients with Hyperphosphataemia.
Topics: Adult; Aged; Bile Acids and Salts; Cholesterol, LDL; Diarrhea; Female; Glycated Hemoglobin; Hemodialysis Solutions; Humans; Hyperphosphatemia; Male; Middle Aged; Nausea; Peptide Fragments; Phosphates; Phosphorus; Procollagen; Renal Dialysis; Renal Insufficiency, Chronic; Uric Acid; Vomiting | 2016 |
Factors associated with serum fetuin-A concentrations after long-term use of different phosphate binders in hemodialysis patients.
Topics: Aged; alpha-2-HS-Glycoprotein; C-Reactive Protein; Calcium; Calcium Carbonate; Chelating Agents; Cholesterol, LDL; Female; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Sevelamer; Treatment Outcome; Triglycerides | 2016 |
Efficacy and safety of nicotinamide in haemodialysis patients: the NICOREN study.
Topics: Adult; Aged; Female; Humans; Hyperphosphatemia; Male; Middle Aged; Niacinamide; Phosphorus; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic; Sevelamer | 2017 |
Dose-response efficacy and safety of PA21 in Japanese hemodialysis patients with hyperphosphatemia: a randomized, placebo-controlled, double-blind, Phase II study.
Topics: Aged; Biomarkers; Chelating Agents; Dose-Response Relationship, Drug; Double-Blind Method; Down-Regulation; Female; Ferric Compounds; Humans; Hyperphosphatemia; Japan; Male; Middle Aged; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Time Factors; Treatment Outcome | 2017 |
Efficacy and safety of sucroferric oxyhydroxide compared with sevelamer hydrochloride in Japanese haemodialysis patients with hyperphosphataemia: A randomized, open-label, multicentre, 12-week phase III study.
Topics: Administration, Oral; Aged; Biomarkers; Calcium; Chelating Agents; Drug Administration Schedule; Drug Combinations; Female; Ferric Compounds; Humans; Hyperphosphatemia; Japan; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Sevelamer; Sucrose; Tablets; Time Factors; Treatment Outcome | 2017 |
Replacing Phosphorus-Containing Food Additives With Foods Without Additives Reduces Phosphatemia in End-Stage Renal Disease Patients: A Randomized Clinical Trial.
Topics: Adult; Aged; Diet; Dietary Proteins; Female; Follow-Up Studies; Food Additives; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Nutritional Status; Nutritive Value; Phosphorus; Phosphorus, Dietary; Renal Dialysis | 2017 |
Higher strength lanthanum carbonate provides serum phosphorus control with a low tablet burden and is preferred by patients and physicians: a multicenter study.
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Drug Administration Schedule; Female; Humans; Hyperphosphatemia; Kidney Diseases; Lanthanum; Male; Middle Aged; Patient Satisfaction; Phosphorus; Renal Dialysis; Tablets; Time Factors; Treatment Outcome; United States | 2008 |
Long-term efficacy and safety profile of lanthanum carbonate: results for up to 6 years of treatment.
Topics: Adult; Aged; Female; Follow-Up Studies; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Phosphates; Phosphorus; Treatment Outcome | 2008 |
Efficacy and safety of sevelamer hydrochloride and calcium acetate in patients on peritoneal dialysis.
Topics: Acetates; Adult; Aged; Calcium Compounds; Chelating Agents; Drug Tolerance; Female; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis; Phosphorus; Polyamines; Sevelamer | 2009 |
Lanthanum carbonate reduces phosphorus burden in patients with CKD stages 3 and 4: a randomized trial.
Topics: Adult; Aged; Aged, 80 and over; Chronic Disease; Double-Blind Method; Female; Humans; Hyperphosphatemia; Kidney Diseases; Lanthanum; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Severity of Illness Index; Time Factors; Treatment Outcome | 2009 |
Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial.
Topics: Adult; Aged; Diet; Female; Food Additives; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Patient Education as Topic; Phosphorus; Renal Dialysis | 2009 |
Impact of vitamin D dose on biochemical parameters in patients with secondary hyperparathyroidism receiving cinacalcet.
Topics: Adult; Calcium; Cinacalcet; Dose-Response Relationship, Drug; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Male; Naphthalenes; Parathyroid Hormone; Phosphorus; Renal Dialysis; Vitamin D | 2009 |
Dietary phosphorus acutely impairs endothelial function.
Topics: Adult; Animals; Brachial Artery; Cardiovascular Diseases; Cattle; Cells, Cultured; Cross-Over Studies; Disease Models, Animal; Double-Blind Method; Endothelium, Vascular; Humans; Hyperphosphatemia; Male; Nitric Oxide; Nitric Oxide Synthase Type III; Oxidative Stress; Phosphorus; Phosphorus, Dietary; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Regional Blood Flow; Risk Factors; Vasodilation | 2009 |
Effect of MCI-196 on serum phosphate and cholesterol levels in haemodialysis patients with hyperphosphataemia: a double-blind, randomized, placebo-controlled study.
Topics: Adult; Aged; Bile Acids and Salts; Cholesterol; Double-Blind Method; Female; Humans; Hyperphosphatemia; Kidney Diseases; Male; Middle Aged; Phosphorus; Renal Dialysis; Young Adult | 2010 |
Hypophosphatemic effect of niacin in patients without renal failure: a randomized trial.
Topics: Aged; Biomarkers; Calcium; Chronic Disease; Delayed-Action Preparations; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Female; Glomerular Filtration Rate; Humans; Hyperphosphatemia; Hypolipidemic Agents; Hypophosphatemia; Indoles; Kidney Diseases; Male; Middle Aged; Niacin; Phosphorus; Receptors, Immunologic; Receptors, Prostaglandin; Severity of Illness Index; Time Factors | 2010 |
Evaluation of calcium acetate/magnesium carbonate as a phosphate binder compared with sevelamer hydrochloride in haemodialysis patients: a controlled randomized study (CALMAG study) assessing efficacy and tolerability.
Topics: Acetates; Adolescent; Adult; Aged; Aged, 80 and over; Alkaline Phosphatase; Calcium Compounds; Female; Humans; Hyperphosphatemia; Magnesium; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Polyamines; Renal Dialysis; Sevelamer | 2010 |
Benefits of sevelamer on markers of bone turnover in Taiwanese hemodialysis patients.
Topics: Acetates; Adult; Aged; Alkaline Phosphatase; Asian People; Biomarkers; Bone Remodeling; Calcium Compounds; Calcium Phosphates; Chelating Agents; Female; Humans; Hypercalcemia; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Phosphorus Metabolism Disorders; Polyamines; Prospective Studies; Renal Dialysis; Sevelamer; Treatment Outcome | 2010 |
Oral nicotinamide reduces serum phosphorus, increases HDL, and induces thrombocytopenia in hemodialysis patients: a double-blind randomized clinical trial.
Topics: Administration, Oral; Adult; Aged; Diarrhea; Double-Blind Method; Female; Humans; Hyperglycemia; Hyperphosphatemia; Kidney Failure, Chronic; Lipoproteins, HDL; Male; Middle Aged; Niacinamide; Phosphorus; Renal Dialysis; Thrombocytopenia | 2011 |
Effect of lanthanum carbonate treatment on bone in Japanese dialysis patients with hyperphosphatemia.
Topics: Adult; Aged; Bone and Bones; Chronic Kidney Disease-Mineral and Bone Disorder; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Phosphorus; Prospective Studies; Renal Dialysis; Young Adult | 2011 |
Clinical efficacy and cost-effectiveness of lanthanum carbonate as second-line therapy in hemodialysis patients in Japan.
Topics: Adolescent; Adult; Aged; Analysis of Variance; Biomarkers; Cardiovascular Diseases; Chelating Agents; Cost-Benefit Analysis; Drug Costs; Female; Humans; Hyperphosphatemia; Japan; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Models, Economic; Phosphorus; Quality-Adjusted Life Years; Renal Dialysis; Time Factors; Treatment Outcome; Young Adult | 2011 |
[The influence of short-term magnesium carbonate treatment on calcium-phosphorus balance in dialysis patients].
Topics: Adult; Aged; Aged, 80 and over; Calcium; Chelating Agents; Female; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Magnesium; Male; Middle Aged; Phosphorus; Polyamines; Renal Dialysis; Sevelamer | 2011 |
Conversion to lanthanum carbonate monotherapy effectively controls serum phosphorus with a reduced tablet burden: a multicenter open-label study.
Topics: Administration, Oral; Adult; Aged; Attitude of Health Personnel; Female; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Patient Satisfaction; Phosphates; Phosphorus; Physicians; Tablets; Treatment Outcome | 2011 |
Lanthanum carbonate reduces urine phosphorus excretion: evidence of high-capacity phosphate binding.
Topics: Administration, Oral; Adolescent; Adult; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Phosphorus; Phosphorus Compounds; Phosphorus, Dietary; Reference Values; Single-Blind Method; Young Adult | 2012 |
Effects of frequent hemodialysis on measures of CKD mineral and bone disorder.
Topics: Adult; Aged; Blood Chemical Analysis; Bone Density; Female; Follow-Up Studies; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Multivariate Analysis; Parathyroid Hormone; Phosphorus; Prospective Studies; Regression Analysis; Renal Dialysis; Risk Factors; Severity of Illness Index; Time Factors | 2012 |
Dietary intervention focused on phosphate intake in hemodialysis patients with hyperphosphoremia.
Topics: Aged; Biomarkers; Calcium; Chi-Square Distribution; Female; Humans; Hyperphosphatemia; Kidney Diseases; Linear Models; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Parathyroid Hormone; Phosphorus; Phosphorus, Dietary; Renal Dialysis; Spain; Time Factors; Treatment Outcome | 2012 |
The effect of intravenous vitamin C on the phosphorus level reduction in hemodialysis patients: a double blind randomized clinical trial.
Topics: Adult; Aged; Ascorbic Acid; C-Reactive Protein; Calcium; Double-Blind Method; Female; Humans; Hyperphosphatemia; Infusions, Intravenous; Male; Middle Aged; Phosphorus; Renal Dialysis; Young Adult | 2012 |
Effect of lanthanum carbonate vs. calcium carbonate on serum calcium in hemodialysis patients: a crossover study.
Topics: Acid Phosphatase; Aged; Alkaline Phosphatase; Analysis of Variance; Calcium; Calcium Carbonate; Chelating Agents; Chi-Square Distribution; Cross-Over Studies; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hypercalcemia; Hyperphosphatemia; Isoenzymes; Lanthanum; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Tartrate-Resistant Acid Phosphatase; Vitamin D | 2012 |
Comparison of efficacy of the phosphate binders nicotinic acid and sevelamer hydrochloride in hemodialysis patients.
Topics: Adult; Aged; Alkaline Phosphatase; Biomarkers; Calcium; Chelating Agents; Female; Humans; Hyperphosphatemia; Iran; Kidney Diseases; Lipids; Male; Middle Aged; Niacin; Parathyroid Hormone; Phosphorus; Polyamines; Renal Dialysis; Sevelamer; Time Factors; Treatment Outcome; Uric Acid | 2012 |
Relationship between reductions in parathyroid hormone and serum phosphorus during the management of secondary hyperparathyroidism with calcimimetics in hemodialysis patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers; Calcimimetic Agents; Comorbidity; Female; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prevalence; Renal Dialysis; Risk Factors; Tennessee; Young Adult | 2012 |
Dose-response and efficacy of ferric citrate to treat hyperphosphatemia in hemodialysis patients: a short-term randomized trial.
Topics: Administration, Oral; Dose-Response Relationship, Drug; Female; Ferric Compounds; Follow-Up Studies; Hematinics; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Prospective Studies; Renal Dialysis; Time Factors; Treatment Outcome | 2013 |
Combined therapy with cinacalcet and low doses of vitamin D sterols in patients with moderate to severe secondary hyperparathyroidism.
Topics: Adult; Aged; Calcium; Cinacalcet; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hyperphosphatemia; Male; Middle Aged; Naphthalenes; Parathyroid Hormone; Phosphorus; Severity of Illness Index; Sterols; Treatment Outcome; Vitamin D | 2008 |
A randomized, double-blind, placebo-controlled trial of niacinamide for reduction of phosphorus in hemodialysis patients.
Topics: Administration, Oral; Biomarkers; Chelating Agents; Cross-Over Studies; Double-Blind Method; Down-Regulation; Drug Therapy, Combination; Female; Humans; Hyperphosphatemia; Kidney Diseases; Male; Middle Aged; Niacinamide; Phosphorus; Prospective Studies; Renal Dialysis; Sodium-Phosphate Cotransporter Proteins; Treatment Outcome; Vitamin B Complex; Vitamin D; Washington | 2008 |
Comparison of sevelamer hydrochloride with colestimide, administered alone or in combination with calcium carbonate, in patients on hemodialysis.
Topics: Adult; Aged; Calcium; Calcium Carbonate; Chelating Agents; Drug Therapy, Combination; Epichlorohydrin; Female; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Imidazoles; Japan; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Polyamines; Prospective Studies; Renal Dialysis; Resins, Synthetic; Sevelamer | 2008 |
Efficacy and tolerability of sevelamer carbonate in hyperphosphatemic patients who have chronic kidney disease and are not on dialysis.
Topics: Aged; Australia; Bicarbonates; Biomarkers; Calcium; Chelating Agents; Cholesterol, LDL; Chronic Disease; Down-Regulation; Europe; Female; Humans; Hyperphosphatemia; Kidney Diseases; Male; Middle Aged; Phosphorus; Polyamines; Renal Dialysis; Sevelamer; Severity of Illness Index; Time Factors; Treatment Outcome; Vitamin D; Vitamins | 2008 |
128 other study(ies) available for phosphorus and Hyperphosphatemia
| Article | Year |
|---|---|
Activation of the Calcium Receptor by Calcimimetic Agents Is Preserved Despite Modest Attenuating Effects of Hyperphosphatemia.
Topics: Aged; Calcimimetic Agents; Cinacalcet; Female; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Male; Middle Aged; Parathyroid Hormone; Peptides; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Retrospective Studies | 2022 |
Hyperphosphatemia is associated with cardiac valve calcification in chronic hypoparathyroidism.
Topics: Carotid Intima-Media Thickness; Female; Heart Valves; Humans; Hyperphosphatemia; Hypertrophy, Left Ventricular; Hypoparathyroidism; Male; Phosphorus; Risk Factors | 2022 |
Safety and effectiveness of ferric citrate hydrate in serum phosphorus management of patients with chronic kidney disease: a long-term, real-world, observational, post-marketing surveillance study.
Topics: Ferric Compounds; Ferritins; Humans; Hyperphosphatemia; Iron; Phosphorus; Product Surveillance, Postmarketing; Prospective Studies; Renal Dialysis; Renal Insufficiency, Chronic | 2022 |
Use of Teriparatide in Hyperphosphatemic Familial Tumor Calcinosis: Evaluating the Interaction Between FGF23 and PTH on the Phosphaturic Effect.
Topics: Calcinosis; Calcitriol; Female; Fibroblast Growth Factors; Humans; Hyperostosis, Cortical, Congenital; Hyperphosphatemia; Hypophosphatemia, Familial; Middle Aged; N-Acetylgalactosaminyltransferases; Neoplasms; Phosphates; Phosphorus; Teriparatide | 2022 |
The effect of egg white diet on phosphorus control in dialysis patients.
Topics: Adolescent; Adult; Calcium; Cholesterol; Diet; Egg White; Humans; Hyperphosphatemia; Malnutrition; Phosphates; Phosphorus; Renal Dialysis; Serum Albumin | 2022 |
A 6-Month clinical practice pilot study of sucroferric oxyhydroxide on nutritional status in patients on peritoneal dialysis.
Topics: Adult; Aged; Drug Combinations; Ferric Compounds; Humans; Hyperphosphatemia; Hypoalbuminemia; Middle Aged; Nutritional Status; Peritoneal Dialysis; Phosphates; Phosphorus; Pilot Projects; Prospective Studies; Serum Albumin; Sucrose | 2022 |
Administration of the probiotic Lactiplantibacillus paraplantarum is effective in controlling hyperphosphatemia in 5/6 nephrectomy rat model.
Topics: Animals; Humans; Hyperphosphatemia; Lactobacillus; Nephrectomy; Phosphates; Phosphorus; Probiotics; Rats; Renal Insufficiency, Chronic | 2022 |
Evaluation of cerium oxide as a phosphate binder using 5/6 nephrectomy model rat.
Topics: Animals; Cerium; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Nephrectomy; Phosphates; Phosphorus; Rats; Renal Insufficiency, Chronic | 2022 |
A real-world analysis of the influence of age on maintenance hemodialysis patients: managing serum phosphorus with sucroferric oxyhydroxide as part of routine clinical care.
Topics: Adult; Aged; Drug Combinations; Humans; Hyperphosphatemia; Phosphorus; Renal Dialysis; Retrospective Studies | 2023 |
Effect of Dietary Phosphorous Restriction on Fibroblast Growth 2 Factor-23 and sKlotho Levels in Patients with Stages 1-2 Chronic Kidney Disease.
Topics: Animals; Cardiovascular Diseases; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Fibroblasts; Glomerular Filtration Rate; Hyperphosphatemia; Phosphorus; Phosphorus, Dietary; Renal Insufficiency, Chronic | 2022 |
A novel
Topics: Calcinosis; Calcium; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Glycosylation; Humans; Hyperostosis, Cortical, Congenital; Hyperphosphatemia; Male; Mutant Proteins; Mutation; Phosphorus; Retrospective Studies; Wheat Germ Agglutinins | 2022 |
Effect of low-dose lanthanum carbonate on calcium and phosphorus metabolism in Asian Patients with end-stage renal disease, maintenance hemodialysis and hyperphosphatemia.
Topics: Calcium; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Phosphorus; Renal Dialysis | 2022 |
Hyperphosphatemia during nutrition recovery in patients with severe anorexia nervosa.
Topics: Adult; Anorexia Nervosa; Female; Humans; Hyperphosphatemia; Phosphorus; Refeeding Syndrome; Retrospective Studies; Weight Gain; Young Adult | 2022 |
The Impact of Medical Nutrition Intervention on the Management of Hyperphosphatemia in Hemodialysis Patients with Stage 5 Chronic Kidney Disease: A Case Series.
Topics: Adult; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Phosphates; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic | 2023 |
Dentoalveolar Alterations in an Adenine-Induced Chronic Kidney Disease Mouse Model.
Topics: Adenine; Animals; Chronic Kidney Disease-Mineral and Bone Disorder; Hyperphosphatemia; Mice; Mice, Inbred C57BL; Phosphorus; Renal Insufficiency, Chronic; X-Ray Microtomography | 2023 |
The impact of cinacalcet in the mineral metabolism markers of patients on dialysis with severe secondary hyperparathyroidism.
Topics: Adult; Aged; Alkaline Phosphatase; Calcimimetic Agents; Calcium; Cinacalcet; Female; Follow-Up Studies; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hyperphosphatemia; Hypocalcemia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Retrospective Studies; Treatment Outcome; Vitamin D | 2019 |
Hyperphosphatemia and risks of acute kidney injury, end-stage renal disease, and mortality in hospitalized patients.
Topics: Acute Kidney Injury; Adult; Aged; Female; Hospitalization; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Mortality; Phosphorus; Retrospective Studies; Risk Factors | 2019 |
Clinically-defined preoperative serum phosphorus abnormalities and outcomes of coronary artery bypass grafting: Retrospective analysis using inverse probability weighting adjustment.
Topics: Aged; Biomarkers; Coronary Artery Bypass; Coronary Artery Disease; Humans; Hyperphosphatemia; Hypophosphatemia; Male; Middle Aged; Phosphorus; Preoperative Period; Proportional Hazards Models; Retrospective Studies; Treatment Outcome | 2019 |
Normal-range emergency department serum phosphorus levels and all-cause mortality.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cause of Death; Emergency Service, Hospital; Female; Hospitalization; Humans; Hyperphosphatemia; Hypophosphatemia; Israel; Male; Middle Aged; Phosphorus; Prognosis; Reference Values; Retrospective Studies | 2021 |
Changes in 3-month mineral and bone disorder patterns were associated with all-cause mortality in prevalent hemodialysis patients with secondary hyperparathyroidism.
Topics: Aged; Bone Diseases; Calcium; Cause of Death; Female; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prognosis; Prospective Studies; Renal Dialysis | 2020 |
The hollow core-shell ferric oxide entrapped chitosan microcapsules as phosphate binders for phosphorus removal in vitro.
Topics: Adsorption; Capsules; Cell Line; Cell Survival; Chitosan; Emulsions; Ferric Compounds; Hemolysis; Humans; Hydrogen-Ion Concentration; Hyperphosphatemia; Iron; Liver; Metal Nanoparticles; Phosphates; Phosphorus; Polymerization; Spectroscopy, Fourier Transform Infrared; Thermogravimetry | 2021 |
Gut Microbiome-Derived Uremic Toxin Levels in Hemodialysis Patients on Different Phosphate Binder Therapies.
Topics: Chelating Agents; Gastrointestinal Microbiome; Humans; Hyperphosphatemia; Phosphates; Phosphorus; Pilot Projects; Renal Dialysis; Sevelamer; Toxins, Biological; Tryptophan; Uremic Toxins | 2022 |
Most consumed processed foods by patients on hemodialysis: Alert for phosphate-containing additives and the phosphate-to-protein ratio.
Topics: Aged; Brazil; Cross-Sectional Studies; Diet; Dietary Proteins; Fast Foods; Female; Food Additives; Food Analysis; Humans; Hyperphosphatemia; Male; Middle Aged; Nitrogen; Nutrition Assessment; Phosphates; Phosphorus; Phosphorus, Dietary; Proteins; Renal Dialysis; Renal Insufficiency, Chronic; Surveys and Questionnaires | 2016 |
[Modelling of phosphorus transfers during haemodialysis].
Topics: Animals; Biomarkers; Humans; Hyperphosphatemia; Magnetic Resonance Spectroscopy; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Treatment Outcome | 2017 |
Real-world effectiveness of sucroferric oxyhydroxide in patients on chronic hemodialysis: A retrospective analysis of pharmacy data
.
Topics: Adult; Aged; Drug Combinations; Female; Ferric Compounds; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Renal Dialysis; Retrospective Studies; Sucrose | 2017 |
Phosphate-Binder Use in US Dialysis Patients: Prevalence, Costs, Evidence, and Policies.
Topics: Calcium; Chelating Agents; Drug and Narcotic Control; Health Care Costs; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Medicare Part D; Needs Assessment; Phosphorus; Renal Dialysis; Sevelamer; United States | 2018 |
Efficacy of sucroferric oxyhydroxide treatment in Japanese hemodialysis patients and its effect on gastrointestinal symptoms.
Topics: Aged; Chelating Agents; Constipation; Diarrhea; Drug Combinations; Drug Therapy, Combination; Female; Ferric Compounds; Humans; Hyperphosphatemia; Japan; Male; Middle Aged; Phosphorus; Renal Dialysis; Sucrose; Time Factors | 2017 |
Real-World Scenario Improvements in Serum Phosphorus Levels and Pill Burden in Peritoneal Dialysis Patients Treated with Sucroferric Oxyhydroxide.
Topics: Adult; Aged; Drug Combinations; Female; Ferric Compounds; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis; Phosphorus; Retrospective Studies; Sucrose | 2018 |
Nutritional status and survival of maintenance hemodialysis patients receiving lanthanum carbonate.
Topics: Adult; Aged; Female; Follow-Up Studies; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Nutritional Status; Phosphates; Phosphorus; Propensity Score; Renal Dialysis; Treatment Outcome | 2019 |
Phosphorus in kidney disease: Culprit or bystander?
Topics: Humans; Hyperphosphatemia; Kidney Diseases; Phosphates; Phosphorus; Phosphorus, Dietary | 2018 |
Accuracy of a Nutrient Database in Estimating the Dietary Phosphorus-to-Protein Ratio and Using a Boiling Method in Low-Phosphate Hospital Diets.
Topics: Cooking; Databases as Topic; Diet; Dietary Proteins; Food Analysis; Food, Formulated; Hospitals; Humans; Hyperphosphatemia; Meals; Nutrients; Phosphates; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic; Taiwan | 2018 |
One-Year Historical Cohort Study of the Phosphate Binder Sucroferric Oxyhydroxide in Patients on Maintenance Hemodialysis.
Topics: Adult; Aged; Chelating Agents; Cohort Studies; Drug Combinations; Female; Ferric Compounds; Humans; Hyperphosphatemia; Male; Medication Adherence; Middle Aged; Nutritional Status; Phosphates; Phosphorus; Renal Dialysis; Renal Insufficiency; Sucrose; Time Factors; Treatment Outcome | 2019 |
Modeled Daily Ingested, Absorbed and Bound Phosphorus: New Measures of Mineral Balance in Hemodialysis Patients.
Topics: Aged; Aged, 80 and over; Chelating Agents; Disease Progression; Feasibility Studies; Feeding Behavior; Female; Humans; Hyperphosphatemia; Intestinal Absorption; Kidney Failure, Chronic; Male; Medication Adherence; Middle Aged; Models, Biological; Phosphorus; Renal Dialysis; Self Report | 2019 |
Impact of lanthanum carbonate on cortical bone in dialysis patients with adynamic bone disease.
Topics: Aged; Bone and Bones; Bone Diseases; Dose-Response Relationship, Drug; Humans; Hyperphosphatemia; Lanthanum; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic | 2013 |
Association of serum phosphorus concentration with mortality in elderly and nonelderly hemodialysis patients.
Topics: Adolescent; Adult; Age Factors; Aged; Cardiovascular Diseases; Cohort Studies; Female; Humans; Hyperphosphatemia; Male; Middle Aged; Phosphorus; Renal Dialysis | 2013 |
Hyperphosphatemia is associated with anemia in adults without chronic kidney disease: results from the National Health and Nutrition Examination Survey (NHANES): 2005-2010.
Topics: Adult; Age Distribution; Aged; Aged, 80 and over; Anemia; Biomarkers; Causality; Comorbidity; Female; Health Care Surveys; Humans; Hyperphosphatemia; Male; Middle Aged; Obesity; Phosphorus; Renal Insufficiency, Chronic; Risk Factors; Sex Distribution; Socioeconomic Factors; Statistics as Topic; United States; Young Adult | 2013 |
Serum phosphorus in people with chronic kidney disease: you are what you eat.
Topics: Cardiovascular Diseases; Chelating Agents; Female; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Phosphates; Phosphorus; Renal Dialysis; Renal Insufficiency, Chronic | 2013 |
Long-term treatment of hyperphosphatemia with bixalomer in Japanese hemodialysis patients.
Topics: Aged; Asian People; Female; Gastrointestinal Agents; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Phosphates; Phosphorus; Polyamines; Renal Dialysis; Treatment Outcome | 2013 |
Calciprotein particle (CPP): a true culprit of phosphorus woes?
Topics: alpha-2-HS-Glycoprotein; Calcium Phosphates; Crystallization; Humans; Hyperphosphatemia; Nanoparticles; Phosphorus; Phosphorus, Dietary; Protein Binding; Renal Insufficiency, Chronic | 2014 |
Managing serum phosphate in haemodialysis patients: time for an innovative approach?
Topics: Adolescent; Adult; Aged; Calcium; Female; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphates; Phosphorus; Renal Dialysis; Surveys and Questionnaires; United Kingdom; Young Adult | 2014 |
Clinical trials. Less of the same--PA21 can reduce pill burden in patients with hyperphosphataemia.
Topics: Chelating Agents; Female; Ferric Compounds; Humans; Hyperphosphatemia; Male; Phosphorus | 2014 |
A comparative study of phosphate binders in patients with end stage kidney disease undergoing hemodialysis.
Topics: Acetates; Adult; Biomarkers; Calcium; Calcium Carbonate; Calcium Compounds; Chelating Agents; Female; Humans; Hypercalcemia; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Phosphorus; Polyamines; Renal Dialysis; Retrospective Studies; Sevelamer; Time Factors; Treatment Outcome | 2014 |
Periodontal status and serum biomarkers levels in haemodialysis patients.
Topics: Adult; Alkaline Phosphatase; Biomarkers; Calcium; Creatinine; Cross-Sectional Studies; Dental Plaque Index; Female; Ferritins; Gingival Hemorrhage; Hemoglobins; Humans; Hyperphosphatemia; Hypoalbuminemia; Iron; Male; Periodontal Attachment Loss; Periodontal Index; Periodontal Pocket; Phosphorus; Potassium; Renal Dialysis; Renal Insufficiency, Chronic; Serum Albumin; Transferrin | 2014 |
Is granular formulation of lanthanum carbonate more effective than chewable tablets?
Topics: Adult; Aged; Chemistry, Pharmaceutical; Female; Humans; Hyperphosphatemia; Lanthanum; Male; Middle Aged; Phosphorus; Renal Dialysis; Retrospective Studies; Tablets | 2014 |
Questionnaire survey and serum phosphorus levels in maintenance hemodialysis patients switching lanthanum carbonate formulation from chewable tablets to granules.
Topics: Adult; Aged; Aged, 80 and over; Chemistry, Pharmaceutical; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Medication Adherence; Middle Aged; Patient Preference; Phosphorus; Renal Dialysis; Surveys and Questionnaires; Tablets | 2014 |
Effects of switching from sevelamer hydrochloride to bixalomer on laboratory parameters in hemodialysis patients.
Topics: Aged; Alkaline Phosphatase; Biomarkers; Calcium; Chelating Agents; Female; Humans; Hyperphosphatemia; Japan; Kidney Failure, Chronic; Lipid Metabolism; Lipids; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Polyamines; Renal Dialysis; Sevelamer | 2014 |
Clinical effects of the new phosphorus binder, bixalomer in hemodialysis patients switched from sevelamer hydrochloride.
Topics: Abdominal Pain; Aged; Calcium; Chelating Agents; Constipation; Diarrhea; Dyspepsia; Female; Gastroesophageal Reflux; Gastrointestinal Diseases; Humans; Hyperphosphatemia; Japan; Kidney Failure, Chronic; Male; Parathyroid Hormone; Phosphorus; Polyamines; Renal Dialysis; Sevelamer; Surveys and Questionnaires | 2014 |
Clinical experiences of bixalomer usage at our hospital.
Topics: Aged; Calcium; Chelating Agents; Female; Follow-Up Studies; Humans; Hydrogen-Ion Concentration; Hyperphosphatemia; Japan; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Polyamines; Prospective Studies; Renal Dialysis; Sevelamer | 2014 |
Treatment of hyperphosphatemia with bixalomer in Japanese patients on long-term hemodialysis with gastrointestinal symptoms.
Topics: Abdominal Pain; Bicarbonates; Calcium; Chelating Agents; Cohort Studies; Constipation; Female; Follow-Up Studies; Gastroesophageal Reflux; Gastrointestinal Diseases; Humans; Hyperphosphatemia; Japan; Kidney Failure, Chronic; Lipids; Male; Middle Aged; Phosphates; Phosphorus; Polyamines; Prospective Studies; Renal Dialysis | 2014 |
Serum magnesium, phosphorus, and calcium are associated with risk of incident heart failure: the Atherosclerosis Risk in Communities (ARIC) Study.
Topics: Atherosclerosis; Biomarkers; Calcium; Cohort Studies; Female; Follow-Up Studies; Heart Failure; Humans; Hypercalcemia; Hyperphosphatemia; Incidence; Magnesium; Magnesium Deficiency; Male; Middle Aged; Phosphorus; Proportional Hazards Models; Risk Factors; United States | 2014 |
Pseudohyperphosphatemia in children treated with liposomal amphotericin B.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Hyperphosphatemia; Infant; Infant, Newborn; Male; Phosphorus; Retrospective Studies; Risk Factors | 2014 |
Novel phosphate binders: plus ça change, plus c'est la même chose.
Topics: Chelating Agents; Female; Ferric Compounds; Humans; Hyperphosphatemia; Male; Phosphorus | 2014 |
Dietary phosphorus intake and distribution in Chinese peritoneal dialysis patients with and without hyperphosphatemia.
Topics: Adult; Aged; Case-Control Studies; China; Cross-Sectional Studies; Diet; Female; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Peritoneal Dialysis; Phosphorus | 2015 |
Spurious hyperphosphatemia related to severe hyperbilirubinemia in patients with end-stage liver disease.
Topics: Bilirubin; Blood Proteins; Calcium; Creatinine; End Stage Liver Disease; Humans; Hyperbilirubinemia; Hyperphosphatemia; Parathyroid Hormone; Phosphorus; Phosphorus, Dietary; Photometry | 2014 |
Determination of peritoneal phosphate transport as a tool for controlling serum phosphorus.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biological Transport; Creatinine; Cross-Sectional Studies; Dialysis Solutions; Female; Humans; Hyperphosphatemia; Male; Middle Aged; Peritoneum; Phosphates; Phosphorus; Urea; Young Adult | 2014 |
Tip-toeing toward the finish line.
Topics: Female; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Phosphorus; Renal Dialysis | 2015 |
Survival advantage of lanthanum carbonate for hemodialysis patients with uncontrolled hyperphosphatemia.
Topics: Aged; Female; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Phosphorus; Renal Dialysis; Retrospective Studies; Survival Rate; Treatment Outcome | 2015 |
The economic impact of improving phosphate binder therapy adherence and attainment of guideline phosphorus goals in hemodialysis patients: a Medicare cost-offset model.
Topics: Adult; Chelating Agents; Cost Savings; Female; Health Care Costs; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Medicare; Medication Adherence; Phosphates; Phosphorus; Practice Guidelines as Topic; Renal Dialysis; Retrospective Studies; United States | 2014 |
Serum phosphorus level is related to degree of clinical response to up-titration of heart failure pharmacotherapy.
Topics: Cardiovascular Agents; Europe; Female; Follow-Up Studies; Heart Failure; Homeostasis; Humans; Hyperphosphatemia; Male; Middle Aged; Phosphorus; Prevalence; Prognosis; Retrospective Studies; Severity of Illness Index | 2014 |
Mineral metabolism in European children living with a renal transplant: a European society for paediatric nephrology/european renal association-European dialysis and transplant association registry study.
Topics: Adolescent; Calcium; Child; Child, Preschool; Europe; Female; Glomerular Filtration Rate; Graft Survival; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hyperphosphatemia; Hypocalcemia; Hypophosphatemia; Infant; Infant, Newborn; Kidney Transplantation; Male; Parathyroid Hormone; Phosphorus; Prevalence; Registries | 2015 |
Serum phosphorus levels in premature infants receiving a donor human milk derived fortifier.
Topics: Birth Weight; Female; Food, Fortified; Gestational Age; Humans; Hyperphosphatemia; Incidence; Infant, Newborn; Infant, Premature; Male; Milk, Human; Phosphorus; Prospective Studies | 2015 |
Self-Motivation Is Associated With Phosphorus Control in End-Stage Renal Disease.
Topics: Adult; Aged; Cross-Sectional Studies; Female; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Linear Models; Male; Medication Adherence; Middle Aged; Motivation; Phosphorus; Pilot Projects; Renal Dialysis; Self Report | 2015 |
Renal formulas pretreated with medications alters the nutrient profile.
Topics: Follow-Up Studies; Humans; Hyperkalemia; Hyperphosphatemia; Infant; Infant Formula; Nutritional Support; Phosphorus; Potassium; Renal Insufficiency, Chronic; Sevelamer | 2015 |
Vitamin D Metabolites and Their Association with Calcium, Phosphorus, and PTH Concentrations, Severity of Illness, and Mortality in Hospitalized Equine Neonates.
Topics: Animals; Animals, Newborn; Calcifediol; Calcitriol; Calcium; Horse Diseases; Horses; Hyperphosphatemia; Hypocalcemia; Logistic Models; Parathyroid Hormone; Phosphorus; Severity of Illness Index; Vitamin D; Vitamin D Deficiency | 2015 |
Prevalence of Phosphorus-Based Additives in the Australian Food Supply: A Challenge for Dietary Education?
Topics: Australia; Diet; Food Additives; Food Labeling; Food Supply; Humans; Hyperphosphatemia; Patient Education as Topic; Phosphorus | 2015 |
Effect of individual health education on hyperphosphatemia in the Hakkas residential area.
Topics: Adult; China; Cross-Sectional Studies; Feeding Behavior; Female; Health Education; Humans; Hyperphosphatemia; Male; Middle Aged; Patient Compliance; Phosphorus; Phosphorus, Dietary; Renal Dialysis; Renal Insufficiency, Chronic; Surveys and Questionnaires | 2015 |
Sex, Age, and the Association of Serum Phosphorus With All-Cause Mortality in Adults With Normal Kidney Function.
Topics: Adult; Age Factors; Aged; Cause of Death; Cohort Studies; Female; Humans; Hyperphosphatemia; Kidney Function Tests; Male; Middle Aged; Phosphorus; Reference Values; Risk Factors; Sex Factors | 2016 |
Bixalomer, a novel phosphate binder with a small swelling index, improves hyperphosphatemia in chronic kidney disease rat.
Topics: Adsorption; Animals; Hyperphosphatemia; Male; Phosphates; Phosphorus; Polyamines; Rats, Wistar; Renal Insufficiency, Chronic; Water | 2015 |
Patient-Reported Factors Associated With Poor Phosphorus Control in a Maintenance Hemodialysis Population.
Topics: Aged; Body Mass Index; Cohort Studies; Cross-Sectional Studies; Ethnicity; Female; Health Knowledge, Attitudes, Practice; Humans; Hyperphosphatemia; Male; Medication Adherence; Middle Aged; Phosphorus; Phosphorus, Dietary; Renal Dialysis; Retrospective Studies; Self Report | 2016 |
[Hyperphosphatemia in Chronic Kidney Disease (CKD)].
Topics: Cardiovascular Diseases; Chronic Kidney Disease-Mineral and Bone Disorder; Humans; Hyperphosphatemia; Kidney; Phosphorus; Renal Insufficiency, Chronic | 2015 |
Psychosocial Factors That Create Barriers to Managing Serum Phosphorus Levels in Pediatric Dialysis Patients: A Retrospective Analysis.
Topics: Adolescent; Child; Child, Preschool; Cross-Sectional Studies; Diet; Electronic Health Records; Female; Humans; Hyperphosphatemia; Male; Peritoneal Dialysis; Phosphorus; Phosphorus, Dietary; Renal Dialysis; Renal Insufficiency, Chronic; Retrospective Studies; Socioeconomic Factors | 2016 |
Health care providers' support of patients' autonomy, phosphate medication adherence, race and gender in end stage renal disease.
Topics: Cross-Sectional Studies; Female; Health Personnel; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Medication Adherence; Middle Aged; Minority Groups; Phosphorus; Self Report; Sex Factors | 2016 |
Mineral and Bone Disorder and Its Association with Cardiovascular Parameters in Chinese Patients with Chronic Kidney Disease.
Topics: Adolescent; Adult; Aged; China; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Glomerular Filtration Rate; Humans; Hyperphosphatemia; Hypertrophy, Left Ventricular; Logistic Models; Male; Middle Aged; Phosphorus; Prospective Studies; Renal Insufficiency, Chronic; Vascular Calcification; Young Adult | 2016 |
Severe hyperphosphatemia after oral laxative administration in a 7-year-old patient.
Topics: Administration, Oral; Child; Humans; Hyperphosphatemia; Laxatives; Male; Phosphates; Phosphorus; Renal Dialysis; Seizures | 2016 |
Hypophosphatemia: nutritional status, body composition, and mortality in hemodialysis patients.
Topics: Aged; Aged, 80 and over; Body Composition; Female; Humans; Hyperphosphatemia; Hypophosphatemia; Kaplan-Meier Estimate; Longitudinal Studies; Male; Middle Aged; Nutritional Status; Phosphorus; Portugal; Prognosis; Proportional Hazards Models; Renal Dialysis; Renal Insufficiency, Chronic; Risk Assessment; Survival Rate | 2017 |
Clinical Epidemiology of Mineral Bone Disorder Markers in Prevalent Hemodialysis Patients in the Xinjiang Uyghur Autonomous Region in China.
Topics: Aged; Calcification, Physiologic; Calcium; China; Chronic Kidney Disease-Mineral and Bone Disorder; Cross-Sectional Studies; Female; Humans; Hyperphosphatemia; Hypocalcemia; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prevalence; Registries; Renal Dialysis; Retrospective Studies | 2017 |
Differences in corrective mode for divalent ions and parathyroid hormone between standard- and low-calcium dialysate in patients on continuous ambulatory peritoneal dialysis--result of a nationwide survey in Japan.
Topics: Adult; Aged; Antacids; Calcium; Calcium Carbonate; Dialysis Solutions; Drug Prescriptions; Health Surveys; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hyperphosphatemia; Japan; Middle Aged; Parathyroid Hormone; Peritoneal Dialysis, Continuous Ambulatory; Phosphorus; Surveys and Questionnaires; Vitamin D; Vitamins | 2008 |
Salivary phosphorus and phosphate content of beverages: implications for the treatment of uremic hyperphosphatemia.
Topics: Beverages; Female; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Phosphate-Binding Proteins; Phosphates; Phosphorus; Renal Dialysis; Saliva | 2009 |
Is it worth correcting hyperparathyroidism if hyperphosphatemia and hypocalcemia worsen? A cinacalcet story.
Topics: Calcium; Cinacalcet; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Hypocalcemia; Kidney Failure, Chronic; Naphthalenes; Phosphorus | 2009 |
Phosphorus and survival: key questions that need answers.
Topics: Chronic Disease; Clinical Trials as Topic; Cohort Studies; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperphosphatemia; Kidney Diseases; Models, Biological; Multivariate Analysis; Phosphates; Phosphorus; Phosphorus, Dietary; Treatment Outcome; Vitamin D | 2009 |
Relationship between serum phosphate and cardiovascular risk factors in a large cohort of adult outpatients.
Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Cholesterol; Creatinine; Female; Humans; Hyperphosphatemia; Male; Middle Aged; Phosphorus; Retrospective Studies; Risk Factors; Triglycerides | 2009 |
Managing bone mineral disorders in CKD: an overview of current therapies.
Topics: Algorithms; Biomarkers; Calcitriol; Calcium; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Decision Trees; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Nephrology; Parathyroid Hormone; Parathyroidectomy; Patient Care Team; Patient Education as Topic; Phosphorus; Practice Guidelines as Topic; Sensitivity and Specificity; Treatment Outcome; Vitamin D | 2009 |
Salivary phosphorus binding: a novel approach to control hyperphosphatemia.
Topics: Chewing Gum; Chitosan; Humans; Hyperphosphatemia; Phosphorus; Renal Insufficiency, Chronic; Saliva | 2009 |
Caring for chronic kidney disease patients: focus on mineral and bone disorders.
Topics: Calcium; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cinacalcet; Diet Therapy; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Kidney Failure, Chronic; Metabolic Diseases; Middle Aged; Naphthalenes; Parathyroid Hormone; Pharmaceutical Services; Phosphorus; Receptors, Calcium-Sensing; Renal Dialysis; Vitamin D | 2009 |
Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients.
Topics: Adult; Aged; Cohort Studies; Comorbidity; Cost of Illness; Cross-Sectional Studies; Female; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Medication Adherence; Middle Aged; Multivariate Analysis; Phosphorus; Predictive Value of Tests; Prevalence; Quality of Life; Renal Dialysis; Sensitivity and Specificity | 2009 |
Unrecognized acute phosphate nephropathy in a kidney donor with consequent poor allograft outcome.
Topics: Acute Disease; Adult; Aged; Calcium Phosphates; Delayed Graft Function; Female; Humans; Hyperphosphatemia; Kidney Diseases; Kidney Transplantation; Kidney Tubules; Male; Middle Aged; Phosphates; Phosphorus; Tissue Donors | 2009 |
Reducing serum phosphorus concentration in patients with end-stage renal disease.
Topics: Diet; Dietary Proteins; Food Additives; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Phosphorus; Renal Dialysis | 2009 |
Dialysis: Phosphorus binders and survival: need for randomized trials.
Topics: Humans; Hyperphosphatemia; Kidney Failure, Chronic; Phosphorus; Randomized Controlled Trials as Topic; Renal Dialysis | 2009 |
Rosuvastatin in patients undergoing hemodialysis.
Topics: Cardiovascular Diseases; Confounding Factors, Epidemiologic; Fluorobenzenes; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hyperphosphatemia; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Phosphorus; Pyrimidines; Renal Dialysis; Rosuvastatin Calcium; Sulfonamides | 2009 |
Association of secondary hyperparathyroidism with CKD progression, health care costs and survival in diabetic predialysis CKD patients.
Topics: Aged; Ambulatory Care; Chelation Therapy; Cohort Studies; Comorbidity; Diabetic Nephropathies; Disease Progression; Drug Costs; Female; Health Care Costs; Health Resources; Hospital Costs; Hospitalization; Humans; Hyperparathyroidism, Secondary; Hyperphosphatemia; Insurance, Health, Reimbursement; Longevity; Male; Middle Aged; Phosphorus; Retrospective Studies; Survival Analysis | 2009 |
Effects of 1,25-dihydroxyvitamin D3 on calcium and phosphorus homeostasis in sheep fed diets either adequate or restricted in calcium content.
Topics: Animal Feed; Animals; Biomarkers; Bone and Bones; Bone Resorption; Calcitriol; Calcium; Calcium, Dietary; Collagen; Female; Hypercalcemia; Hyperphosphatemia; Peptide Fragments; Phosphates; Phosphorus; Sheep, Domestic | 2010 |
Targeting hyperphosphatemia: truth or dare.
Topics: Humans; Hyperphosphatemia; Phosphorus; Randomized Controlled Trials as Topic; Renal Dialysis | 2010 |
Effect of paricalcitol and cinacalcet on serum phosphate, FGF-23, and bone in rats with chronic kidney disease.
Topics: Animals; Biomarkers; Bone Resorption; Calcitriol; Calcium; Cinacalcet; Creatinine; Disease Models, Animal; Ergocalciferols; Female; Fibroblast Growth Factors; Hyperparathyroidism; Hyperphosphatemia; Hypocalcemia; Naphthalenes; Nephrectomy; Parathyroid Hormone; Phosphorus; Rats; Rats, Sprague-Dawley; Receptors, Calcium-Sensing; Renal Insufficiency, Chronic; Severity of Illness Index; Tibia; Uremia | 2010 |
Serum phosphorus levels and the spectrum of ankle-brachial index in older men: the Osteoporotic Fractures in Men (MrOS) study.
Topics: Aged; Analysis of Variance; Ankle Brachial Index; Chi-Square Distribution; Cross-Sectional Studies; Fractures, Bone; Humans; Hyperphosphatemia; Hypophosphatemia; Kidney Failure, Chronic; Logistic Models; Male; Men; Osteoporosis; Peripheral Vascular Diseases; Phosphorus; Prevalence; Risk Factors; Statistics, Nonparametric; Surveys and Questionnaires; United States | 2010 |
Effect of intensified diet education on serum phosphorus and knowledge of pediatric peritoneal dialysis patients.
Topics: Adolescent; Child; Diet; Female; Health Knowledge, Attitudes, Practice; Hispanic or Latino; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Parents; Patient Education as Topic; Peritoneal Dialysis; Phosphorus; Sex Factors; Young Adult | 2010 |
Outcomes associated with serum phosphorus level in males with non-dialysis dependent chronic kidney disease.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Chi-Square Distribution; Creatinine; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Phosphorus; Prognosis; Proportional Hazards Models; Retrospective Studies; Severity of Illness Index; Survival Analysis | 2010 |
Efficacy and safety of SBR759, a new iron-based phosphate binder.
Topics: Adult; Aged; Aged, 80 and over; Drug Combinations; Female; Ferric Compounds; Humans; Hyperphosphatemia; Iron; Kidney Failure, Chronic; Magnesium; Male; Middle Aged; Phosphates; Phosphorus; Phosphorus, Dietary; Renal Dialysis; Renal Insufficiency, Chronic; Safety; Starch | 2010 |
[Radiology image of lanthanum carbonate].
Topics: Abdominal Pain; Artifacts; Chelating Agents; Chelation Therapy; Colon; Diabetic Nephropathies; Diagnosis, Differential; Diverticulitis, Colonic; Diverticulosis, Colonic; Fever; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Lanthanum; Male; Middle Aged; Phosphorus; Renal Dialysis; Tomography, X-Ray Computed | 2010 |
Impact of poverty on serum phosphate concentrations in the Third National Health and Nutrition Examination Survey.
Topics: Adult; Cross-Sectional Studies; Diet; Female; Health Status; Humans; Hyperphosphatemia; Income; Kidney Failure, Chronic; Male; Middle Aged; Multivariate Analysis; Nutrition Surveys; Phosphates; Phosphorus; Phosphorus, Dietary; Poverty; Regression Analysis; Social Class; Surveys and Questionnaires; United States | 2011 |
Elevated preoperative phosphorus levels are an independent risk factor for cardiovascular mortality.
Topics: Aged; Cardiovascular Diseases; Cause of Death; Female; Glomerular Filtration Rate; Heart Failure; Humans; Hyperphosphatemia; Male; Middle Aged; Multivariate Analysis; Peripheral Arterial Disease; Phosphorus; Preoperative Period; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Treatment Outcome; Vascular Surgical Procedures | 2010 |
Increased parathyroid expression of klotho in uremic rats.
Topics: Animals; Calcitriol; Calcium; Disease Models, Animal; Fibroblast Growth Factors; Glucuronidase; Hyperparathyroidism, Secondary; Hyperphosphatemia; Klotho Proteins; Male; Nephrectomy; Parathyroid Glands; Parathyroid Hormone; Phosphorus; Rats; Rats, Wistar; Receptor, Fibroblast Growth Factor, Type 1; Receptors, Calcitriol; Receptors, Calcium-Sensing; RNA, Messenger; Sodium-Potassium-Exchanging ATPase; Up-Regulation; Uremia | 2010 |
Erroneous determination of hyperphosphatemia ('pseudohyperphosphatemia') in sera of patients that have been treated with liposomal amphotericin B (AmBisome).
Topics: Amphotericin B; Artifacts; Blood Chemical Analysis; Diagnostic Errors; Humans; Hyperphosphatemia; Phosphorus | 2010 |
Outcomes associated with phosphorus binders in men with non-dialysis-dependent CKD.
Topics: Aged; Bone Density Conservation Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Female; Glomerular Filtration Rate; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Off-Label Use; Phosphates; Phosphorus; Renal Dialysis; Retrospective Studies; Treatment Outcome | 2010 |
The bone and mineral disorder of children undergoing chronic peritoneal dialysis.
Topics: Adolescent; Calcium; Child; Child, Preschool; Cinacalcet; Europe; Female; Follow-Up Studies; Humans; Hyperphosphatemia; Hypocalcemia; Infant; Kidney Failure, Chronic; Latin America; Male; Naphthalenes; North America; Parathyroid Hormone; Peritoneal Dialysis; Phosphate-Binding Proteins; Phosphorus; Prospective Studies; Registries; Vitamin D; Young Adult | 2010 |
Hyperphosphataemia is associated with the diabetes-related cardiovascular risk factors.
Topics: Aged; Blood Glucose; Cardiovascular Diseases; Case-Control Studies; Diabetes Complications; Fasting; Glycated Hemoglobin; Humans; Hyperphosphatemia; Lipids; Middle Aged; Phosphorus; Risk Factors | 2011 |
Education for dialysis patients lowers long-term phosphate levels and maintains health-related quality of life.
Topics: Adult; Aged; Aged, 80 and over; Chelating Agents; Female; Health Knowledge, Attitudes, Practice; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Patient Education as Topic; Phosphorus; Quality of Life; Renal Dialysis; Statistics, Nonparametric; Surveys and Questionnaires; Treatment Outcome | 2011 |
Inorganic phosphorus homeostasis during the first hour of dialysis.
Topics: 2,3-Diphosphoglycerate; Adult; Aged; Aged, 80 and over; Biomarkers; Erythrocytes; Female; Follow-Up Studies; Homeostasis; Humans; Hyperphosphatemia; Intracellular Fluid; Kidney Failure, Chronic; Male; Middle Aged; Phosphates; Phosphorus; Renal Dialysis; Time Factors | 2011 |
Seasonal changes in phosphorus content of fish tissue as they relate to diets of renal patients.
Topics: Animals; Diet; Dietetics; Humans; Hyperphosphatemia; Kidney Diseases; Lebanon; Perciformes; Phosphorus; Phosphorus, Dietary; Renal Dialysis; Sea Bream; Seafood; Seasons | 2012 |
Interaction of time-varying albumin and phosphorus on mortality in incident dialysis patients.
Topics: Aged; Austria; Biomarkers; Female; Humans; Hyperphosphatemia; Hypoalbuminemia; Kidney Failure, Chronic; Linear Models; Male; Middle Aged; Phosphorus; Proportional Hazards Models; Prospective Studies; Renal Dialysis; Risk Assessment; Risk Factors; Serum Albumin; Time Factors | 2011 |
Effectiveness and cost-efficacy of phosphate binders in hemodialysis.
Topics: Adult; Aged; Calcium; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Cost Savings; Health Care Costs; Hemodialysis Solutions; Humans; Hypercalcemia; Hyperparathyroidism, Secondary; Hyperphosphatemia; Lanthanum; Parathyroid Hormone; Phosphorus; Polyamines; Renal Dialysis; Renal Insufficiency, Chronic; Sevelamer; Technology Assessment, Biomedical | 2011 |
CKD-mineral and bone disorder: core curriculum 2011.
Topics: Bone Diseases; Calcinosis; Calciphylaxis; Calcitriol; Calcium; Chelating Agents; Chronic Kidney Disease-Mineral and Bone Disorder; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Hyperphosphatemia; Kidney; Kidney Failure, Chronic; Kidney Tubules; Lanthanum; Parathyroid Hormone; Parathyroidectomy; Phosphorus; Polyamines; Practice Guidelines as Topic; Renal Dialysis; Renal Insufficiency, Chronic; Sevelamer; Vitamin D | 2011 |
Relationship between serum phosphorus and the progression of advanced chronic kidney disease.
Topics: Aged; Bicarbonates; Biomarkers; Calcitriol; Calcium; Chelating Agents; Chronic Disease; Confounding Factors, Epidemiologic; Disease Progression; Diuretics; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Hyperphosphatemia; Kidney Diseases; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Predictive Value of Tests; Prospective Studies | 2011 |
Effects of phosphonoformic acid and renagel on renal type IIa sodium-dependent phosphate cotransporter mRNA expression in hyperphosphatemia rats.
Topics: Animals; Chelating Agents; Disease Models, Animal; Follow-Up Studies; Foscarnet; Gene Expression Regulation; Hyperphosphatemia; Male; Phosphorus; Polyamines; Rats; Rats, Sprague-Dawley; Real-Time Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; RNA, Messenger; Sevelamer; Sodium-Phosphate Cotransporter Proteins, Type IIa | 2012 |
Sevelamer hydrochloride binds phosphate released from phytate in chicks fed 1α-hydroxy cholecalciferol.
Topics: Animal Feed; Animals; Chickens; Diet; Hydroxycholecalciferols; Hyperphosphatemia; Male; Minerals; Phosphates; Phosphorus; Phosphorus, Dietary; Phytic Acid; Polyamines; Sevelamer; Weight Gain | 2013 |
Hyperphosphatemia is associated with overt proteinuria in non-diabetic patients with late-stage chronic kidney disease: a cross-sectional study.
Topics: Aged; Aged, 80 and over; Analysis of Variance; Cholesterol; Confidence Intervals; Creatinine; Cross-Sectional Studies; Female; Humans; Hypercholesterolemia; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Odds Ratio; Phosphorus; Proteinuria; Retrospective Studies | 2013 |
Tumoral calcinosis--a pathogenetic overview: a histological and ultrastructural study with a report of two new cases, one in infancy.
Topics: Calcinosis; Child; Histiocytes; Humans; Hyperphosphatemia; Infant, Newborn; Male; Mitochondria; Necrosis; Osteoclasts; Phosphorus; Skin Diseases; Soft Tissue Injuries; Wounds and Injuries | 2012 |
Relationship between aortic mineral elements and osteodystrophy in mice with chronic kidney disease.
Topics: Animals; Aorta, Thoracic; Calcium; Chronic Kidney Disease-Mineral and Bone Disorder; Disease Resistance; Early Diagnosis; Hyperparathyroidism, Secondary; Hyperphosphatemia; Magnesium; Male; Mice; Mice, Inbred ICR; Phosphorus; Renal Insufficiency, Chronic; Severity of Illness Index; Spectrophotometry, Atomic; Spectrophotometry, Infrared; Thoracic Vertebrae; Tomography, X-Ray Computed; Vascular Calcification | 2012 |
Mineral and bone disorder in Chinese dialysis patients: a multicenter study.
Topics: Adult; Aged; Asian People; Biomarkers; Bone Diseases; Calcium; Cross-Sectional Studies; Female; Humans; Hyperphosphatemia; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Renal Dialysis | 2012 |
Correlates of parathyroid hormone concentration in hemodialysis patients.
Topics: Alkaline Phosphatase; Biomarkers; Calcium; Cohort Studies; Female; Humans; Hypercalcemia; Hyperparathyroidism; Hyperphosphatemia; Male; Middle Aged; Parathyroid Hormone; Phosphorus; Prognosis; Renal Dialysis; Renal Insufficiency, Chronic; Risk Factors | 2013 |
Improvement of therapeutic compliance in haemodialysis patients with poor phosphorus control and adherence to treatment with binders: COMQUELFOS study.
Topics: Adult; Aged; Aged, 80 and over; Chelating Agents; Female; Follow-Up Studies; Humans; Hyperphosphatemia; Male; Medication Adherence; Middle Aged; Phosphorus; Prospective Studies; Renal Dialysis; Surveys and Questionnaires; Young Adult | 2013 |
Adherence to phosphate binder therapy is the primary determinant of hyperphosphatemia incidence in patients receiving peritoneal dialysis.
Topics: Adult; Female; Humans; Hyperphosphatemia; Incidence; Male; Medication Adherence; Middle Aged; Multivariate Analysis; Peritoneal Dialysis; Phosphates; Phosphorus; Renal Insufficiency, Chronic; Retrospective Studies | 2013 |
[Hyperphosphatemia as a symptom of tubular insufficiency].
Topics: Humans; Hyperphosphatemia; Kidney Diseases; Phosphorus; Phosphorus, Dietary | 1956 |
A new approach to the evaluation of hyperphosphatemia in chronic kidney disease.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Creatinine; Female; Glomerular Filtration Rate; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Phosphates; Phosphorus; Saliva | 2007 |
Low prevalence of hyperphosphatemia independent of residual renal function in peritoneal dialysis patients.
Topics: Dietary Proteins; Female; Humans; Hyperphosphatemia; Kidney; Kidney Failure, Chronic; Kidney Function Tests; Male; Middle Aged; Nutritional Status; Parathyroid Hormone; Peritoneal Dialysis, Continuous Ambulatory; Phosphorus; Phosphorus, Dietary; Prevalence; Vitamin D | 2007 |
Comparison of chronic renal failure rats and modification of the preparation protocol as a hyperphosphataemia model.
Topics: Adenine; Administration, Oral; Animals; Blood Urea Nitrogen; Chelating Agents; Creatinine; Diet; Disease Models, Animal; Disease Progression; Hyperphosphatemia; Kidney Failure, Chronic; Male; Nephrectomy; Phosphorus; Polyamines; Rats; Rats, Wistar; Reproducibility of Results; Sevelamer; Time Factors; Up-Regulation | 2008 |
Mineral metabolism and mortality in dialysis patients: a reassessment of the K/DOQI guideline.
Topics: Adult; Aged; Bone and Bones; Calcium; Cause of Death; Comorbidity; Female; Follow-Up Studies; Humans; Hypercalcemia; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Netherlands; Parathyroid Hormone; Peritoneal Dialysis; Phosphorus; Practice Guidelines as Topic; Proportional Hazards Models; Prospective Studies; Renal Dialysis; Risk; Serum Albumin | 2008 |
Phosphorus control in peritoneal dialysis patients.
Topics: Adult; Aged; Alkaline Phosphatase; Biological Transport; Calcium; Creatinine; Cross-Sectional Studies; Female; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Male; Middle Aged; Parathyroid Hormone; Peritoneal Dialysis; Phosphorus | 2008 |
Hyperphosphoremia in kidney failure- salivary phosphate as a marker and possible target.
Topics: Biomarkers; Humans; Hyperphosphatemia; Kidney Failure, Chronic; Phosphorus; Saliva | 2008 |